Device for interacting with neurological tissue and methods of making and using the same

Information

  • Patent Grant
  • 10966620
  • Patent Number
    10,966,620
  • Date Filed
    Friday, May 15, 2015
    9 years ago
  • Date Issued
    Tuesday, April 6, 2021
    3 years ago
Abstract
Described herein are microelectrode devices to provide localized neural recording or neural stimulation to a neurological target. The device includes a plurality of electrodes disposed along the shafts of deployable flexible pins. The deployable flexible pins are enclosed within an elongated probe shaft, and can be expanded from their enclosure. Additionally, a specifically manufactured outer housing can be coupled to at least a portion of the elongated probe shaft. During deployment of the flexible pins the outer housing of the microelectrode device reduces friction between the flexible pins and the probe shaft and reduces delamination of the flexible pins during deployment.
Description
BACKGROUND

Medical devices can interact with tissue of a subject to diagnose or treat the subject. For example, the subject can have neurological pathologies, which need to be diagnosed and treated.


SUMMARY

Neural recording and neurostimulation devices can be used in the cochlea, the retina, the peripheral nervous system, the spine, the brain, and other parts of the body. Generally, neural recording can be performed in deep brain structures by surgically inserting conductive electrodes and amplifying neurological signals using external electronic equipment. Neurostimulation can be performed by surgically implanting conductive electrodes in the target, and using an implantable pulse generator to apply electrical signals to the conductive electrodes.


The conductive electrodes can be inserted into the deep brain structures through stereotaxy or endoscopy procedures. During these procedures a lead cannula can be implanted near the target tissue. The conductive electrodes can be fed through the cannula to the target tissue.


Described herein are microelectrode devices to provide highly localized neural recording or neural stimulation to a neurological target. The device includes a plurality of electrodes disposed along the shafts of deployable flexible pins. The deployable flexible pins are enclosed within an elongated probe shaft, and can be expanded from their enclosure. Additionally, a specifically manufactured protective housing can be coupled to at least a portion of the elongated probe shaft. During deployment of the flexible pins, the protective housing of the microelectrode device reduces friction between the flexible pins and the probe shaft and thus reduces the risk of delamination to the flexible pins during deployment.


According to one aspect of the disclosure, an implantable microelectrode device includes an elongated shaft having an outer wall and a distal end. The elongated shaft defines an internal lumen therethough and the outer wall defines a plurality of windows therein. An end cap is coupled with the distal end of the elongated shaft. The end cap has a frustum end projecting into the internal lumen of the elongated shaft. The device also includes a protective tube coupled with the outer surface of the elongated shaft. A portion of the protective tube covers a portion of each of the plurality of windows. The device also includes a probe assembly. The probe assembly includes a plurality of flexible pins. Each of the plurality of flexible pins can be deployed through a different one of the plurality of windows. Each of the plurality of flexible pins exit the elongated shaft at an angle defined by the frustum end of the end cap and a distal end of the protective tube.


In some implementations, the protective tube is configured to substantially reduce a friction induced on the plurality of flexible pins during deployment through the plurality of windows. Compared to a device without the protective tube, the protective tube may reduce the friction induced on the plurality of flexible pins during deployment by between about 50% and about 20%. The protective tube can include a polymeric material. In some implementations, the protective tube and the plurality of flexible pins include a same substrate material. The plurality of flexible pins can be configured to slide along the frustum end of the end cap projecting into the internal lumen and the protective tube. The coefficient of friction between the protective tube and the plurality of flexible pins may be between about 0.5 and about 0.01 or between about 0.2 and about 0.01.


In some implementations, the microelectrode device can also include a microelectromechanical system (MEMS) component that can include a first plurality of MEMS legs. Each of the first plurality of MEMS legs can be aligned and coupled with an outer face of one of the plurality of flexible pins. The device can also include a second plurality of MEMS legs that can be coupled to the first plurality of MEMS legs by a foldable strip. Each of the second plurality of MEMS legs can be aligned and coupled with an inner face of one of the plurality of flexible pins. The MEMS leas can include at least one electrode.


In some implementations, at least one electrode is disposed on each of the plurality of flexible pins. The probe assembly can further include a central pin that is deployed through a central channel of the end cap. The frustum end of the end cap can define the minimum exit angle of the flexible pins from the elongated shaft. The protective tube can define the maximum exit angle of the flexible pins from the elongated shaft. In some implementations, the device includes at least four windows.


The device can include a translation system. The translation system can include a translation ring and a translator rod. The translation system can be configured to convert a rotational movement of the translation ring into an axial movement of the translator rod. The translator rod is coupled to the probe assembly. In some implementations, the translation system includes a second translation ring that is configured to convert a rotational movement into an axial movement to deploy the central pin.


According to another aspect of the disclosure, a method for obtaining neurological activity data includes implanting a microelectrode device within a vicinity of a neurological target. The device includes an elongated shaft having an outer wall and a distal end. The elongated shaft defines an internal lumen and the outer wall defines a plurality of windows. The device also includes an end cap coupled with the distal end of the elongated shaft. The end cap has a frustum end projecting into the internal lumen of the elongated shaft. The device also includes a protective tube coupled with the outer surface of the elongated shaft. Portions of the protective tube cover a portion of each of the plurality of windows. The device further includes a probe assembly that includes a plurality of flexible pins. Each of the plurality of flexible pins includes a plurality of electrode sites. The method also includes deploying at least one of the plurality of flexible pins through a different one of the plurality of windows. The plurality of flexible pins can deploy at an exit angle defined by the frustum end of the end cap and a distal end of the protective tube. The method further includes recording the neurological activity using the plurality of electrode sites.


In some implementations, the method can include coupling the microelectrode device with a stereotactic apparatus. The plurality of flexible pins may be deployed by rotating a translator ring of the microelectrode device. In some implementations, the microelectrode device can include multiple translator rings to enable independent deployment of the flexible pins. The plurality of flexible pins can be retracted and the neurological probe can be removed from the neurological target. The position of the neurological probe within the brain of a subject can be determined responsive to the recorded neurological activity. The method can include coupling the neurological probe with a neural recording and neurostimulation device.


In some implementations, the protective tube is configured to substantially reduce a friction induced on the plurality of flexible pins during deployment through the plurality of windows. The protective tube can include a polymeric material. The protective tube and the plurality of flexible pins can include a same substrate material. A minimum of the exit angle can be defined by the frustum of the end cap, and a maximum of the exit angle can be defined by the distal end of the protective tube. In some implementations, the at least four windows are defined in the outer wall of the elongated shaft. In some implementations, the method includes sliding the plurality of flexible pins along the frustum end projecting into the internal lumen and the protective tube.


In some implementations, the method includes applying a rotational force to a rotational translation system. The rotational translation system can include a translator rod. The rotational translation system is configured to convert the rotational force applied to the rotational translation system into an axial movement of the translator rod. The translator rod can be coupled to the probe assembly.





BRIEF DESCRIPTION OF THE DRAWINGS

The figures, described herein, are for illustration purposes. Various aspects of the described implementations may be shown exaggerated or enlarged to facilitate an understanding of the described implementations. In the drawings, like reference characters generally refer to like features, functionally similar or structurally similar elements throughout the various drawings. The drawings are not necessarily to scale. The drawings are not intended to limit the scope of the present teachings in any way. The systems and methods may be understood from the following illustrative description with reference to the following drawings in which:



FIG. 1 is a perspective view of one implementation of a microelectrode device.



FIG. 2A is a planar view of an exemplary inner stent sub-assembly, suitable for use in the microelectrode device of FIG. 1.



FIGS. 2B and 2C are views of an exemplary microelectrode probe assembly, suitable for use in the microelectrode device of FIG. 1.



FIGS. 2D-2F illustrate the subcomponents of the microelectrode probe assembly, suitable for use in the microelectrode device of FIG. 1.



FIGS. 2G-2J illustrate various views of foldable extension legs, suitable for use in the microelectrode device of FIG. 1.



FIGS. 3A-3H illustrate various views of an example connection pad, suitable for use in the microelectrode device of FIG. 1.



FIGS. 3I, 3J, and 3K illustrate various views of coupling a polymeric insulation layer to a flexible cable, suitable for use in the microelectrode device of FIG. 1.



FIG. 4A is a planar view of an exemplary outer stent sub-assembly, suitable for use in the microelectrode device of FIG. 1.



FIG. 4B is a planar view of the outer stent sub-assembly of FIG. 4A with a protective tube.



FIG. 4C is a cross-sectional view of the outer stent sub-assembly of FIG. 4B.



FIG. 5A is a perspective view of the tip of the microelectrode device of FIG. 1 in an undeployed state.



FIG. 5B is a cross-sectional view of the tip of the microelectrode device of FIG. 1 in an undeployed state.



FIG. 6A is a perspective view of the tip of the microelectrode device of FIG. 1 in a deployed state.



FIG. 6B is a cross-sectional view of the tip of the microelectrode device of FIG. 1 in a deployed state.



FIGS. 6C-6H illustrate the tip of the microelectrode drive with an independently controllable central pin.



FIGS. 6I and 6J illustrate the tip of the microelectrode drive with a fixed central pin.



FIG. 7A is a planar view of an exemplary translation system, suitable for use in the microelectrode device of FIG. 1.



FIG. 7B is a cross-sectional view of the translation system of FIG. 7A.



FIG. 7C is a cross-sectional view of an exemplary translation system, suitable for use in the microelectrode device of FIG. 1.



FIG. 7D is an exploded view of the exemplary translation system of FIG. 7C.



FIG. 7E illustrates a cross-sectional view of the translation system of FIG. 7A.



FIG. 7F is a side view of the translator rod and guiding tube of the exemplary translation system of FIG. 7C.



FIGS. 7G-7J illustrate the guiding structures moving along the guiding tube of the translation system of FIG. 7C.



FIGS. 8A and 8B are side and cross-sectional views, respectively, illustrating an exemplary indexing system suitable for use in the microelectrode device of FIG. 1.



FIGS. 8C-8G illustrate how the various components of the indexing system fit together.



FIGS. 9A-9E illustrate the systematic disassembling of the translation system.



FIGS. 10A-10D illustrate views of an example translation system with multiple translator rings.



FIGS. 11A, 11B, and 11C illustrate how the translation system interacts with an example stereotactic apparatus.



FIG. 12 illustrates the interaction of the translation system and a portion of a stereotactic frame to prevent removal of the microelectrode device.





DETAILED DESCRIPTION

The various concepts introduced above and discussed in greater detail below may be implemented in any of numerous ways, as the described concepts are not limited to any particular manner of implementation. Examples of specific implementations and applications are provided primarily for illustrative purposes. Medical devices discussed herein can perform neural recording and neurostimulation operations to interact electrically with tissue. In the case of neural recording, physiological measurements can be performed on neurological tissue to diagnose or treat a patient. In the case of neurostimulation, an electric charge can be transferred to the tissue in order to create a therapeutic outcome or to generate a diagnosis.


Described herein are microelectrode array devices, and methods of fabrication and use of the same, to provide localized and efficient electrical stimulation of a neurological target, such as individual neurons, groups of neurons, and neural tissue as may be located in an animal nervous system, such as deep within a human or animal brain. In small, difficult to find brain targets such as the Pedunculopontine Nucleus, or in targets that require localized levels of neural stimulation, such as the Subthalamic Nucleus, many microelectrodes are required in the brain region to find the target using electrophysiological recording. A higher number of microelectrodes can increase the chance of finding the neurons required for therapeutic stimulation. The microelectrode or group of microelectrodes that are closest to the target brain region can be used for chronic, therapeutic stimulation or inhibition.


The stimulation can be highly localized. In some implementations, the stimulation is localized by using small electrodes—for example between about 2 μm and about 2 mm in either of diameter or width. The relative spacing between such microelectrode elements can be between about 2 μm and about 2 mm. In some examples, microelectrodes of about 150 μm in diameter, with about a 1000 μm spacing are used to stimulate neural tissue. An array of such microelectrode elements may include one or more such elements (e.g., sixteen elements), each disposed at a respective position or site.


Smaller microelectrode elements can provide neurological stimulation that is highly localized and efficient because an array of such microelectrodes can identify the stimulation region of interest. For example, one or more microelectrode elements of such an array of microelectrode elements can be used to record neuronal activity in the vicinity of the detecting or recording microelectrode elements. Such refinement offered by the relatively small size or spacing of the microelectrode elements can be used to obtain a highly localized map of neuronal activity in the region surrounding the implant. A suitably dimensioned microelectrode array having multiple microelectrode elements positioned in a general vicinity of a neurological target, can be used to locate a precise neurological target without further repositioning, by identifying those one or more microelectrode elements located in a very specific region of the neurological target. The microelectrode array can be programmed to stimulate in a very specific region, for example, using a certain number of the microelectrode elements to actively stimulate the surrounding neurons or neuronal tissue, while other electrode elements of the array remain inactive.


In some embodiments, the microelectrode arrays are positioned in three-dimensional spaces, rather than implanted as linear arrays or two-dimensional arrays on films. The microelectrode arrays can be positioned along shafts, which radiate from a central lumen in order to cover the target tissue.


In some embodiments, an elongated device that includes microelectrode arrays having elements with relatively small size or spacing can be used to obtain a highly localized map of neuronal activity in the region surrounding the implant. For example, such a device configured with a linear array of microelectrodes positioned along a length of a distal end of the device can be placed into a patient's brain. The elements of the microelectrode array can envelop a region including the neurological target. Neurological activity can be independently detected by one or more of the microelectrode elements. The detected activity may be captured in a recorder or display device, allowing a clinician to identify which one or more of the microelectrode elements is positioned closest to the intended target. Knowing a respective location of each of the microelectrode elements along the device, and determining the distance to a reference, such as the patient's skull, a precise location of the target can be determined as the distance along a trajectory of the device. The distance is measured from the reference to the particular microelectrode element. The location of the target can be determined without any repositioning of the elongated device, thereby simplifying the medical procedure.


In some embodiments, the device is for acute intra-surgical use; being removed after the target has been located. The device can be replaced with a chronic probe or positioned at the determined target location. The device can be left in place as a chronic device, with the same microelectrodes or different ones used to record or stimulate the neurological target over an extended period of time.


In some implementations, the microelectrode device described herein includes inner and outer stent subassemblies. The outer stent subassembly can include an elongated shaft that defines an internal lumen. Multiple windows are defined in the wall of the elongated shaft towards elongated shaft's distal end. The microelectrode device also includes an end cap coupled with the distal end of the elongated shaft. A portion of the end cap includes a frustum end. The frustum end of the end cap projects into the internal lumen of the elongated shaft. A protective tube can be coupled with an outer surface of the elongated shaft. The protective tube can cover a portion of each of the windows. The microelectrode device can also include a probe assembly. The probe assembly is configured to slid through the internal lumen of the elongated shaft. The probe assembly can include flexible pins. Each of the flexible pins arc aligned with one of the windows defined in the elongated shaft such that the flexible pins can deploy through the window. The angle at which the flexible pins are deployed through the window is defined, at least in part, by the frustum end of the end cap and a distal end of the protective tube.



FIG. 1 illustrates an exemplary implementation of a microelectrode device 100. The microelectrode device 100 can include at least one elongated microelectrode lead assembly 105. The lead assembly 105 can include at least one outer stent sub-assembly 240 and at least one inner stent sub-assembly 270. As illustrated in FIG. 1, the microelectrode device 100 is in a deployed state. In the deployed state, the distal end of the inner stem sub-assembly 270 can be visible as its microelectrode probe assembly protrudes out of the outer stent sub-assembly 240. At least one translation system 300 (also referred to as a controller 300) can be coupled with the proximal end of the lead assembly 105.


The outer stent sub-assembly 240 can provide a protective housing through which the inner stent sub-assembly 270 slides when driven by the translation system 300. In some implementations, the walls of the outer stent sub-assembly 240 form an elongated shaft that defines an internal lumen. The inner stent sub-assembly 270 can run through the internal lumen of the outer stent sub-assembly 240. The translation system 300 can be controlled by an operator and can enable the operator to select to what length each of the flexible pins of the microelectrode probe assembly is deployed.



FIG. 2A illustrates an example inner stent sub-assembly 270. The inner stent sub-assembly 270 includes a microelectrode probe assembly 600 coupled to the distal end of a stent tube 271. The microelectrode probe assembly 600 is also illustrated in FIGS. 2B and 2C. In some implementations, the stent tube 271 makes up the majority of the length of the inner stent sub-assembly 270. The inner stent sub-assembly 270 can vary in length and diameter but is generally at least about 28 cm long, (e.g., at least 20 cm long, at least 25 cm long, at least 28 cm long, at least 30 cm long, etc. and around 1.27 mm in diameter (e.g., in the range of 1.0-2.0 mm in diameter).



FIGS. 2B and 2C illustrate views of the exemplary microelectrode probe assembly 600. As described above, the microelectrode probe assembly 600 can be coupled to the distal end of the stent tube 271. As revealed by the cut-a-way view of the stent tube 271, the stent tube 271 can be hollow. The stent tube 271 can also be solid or non-hollow. An electrical connection (such as a conductive wire or flexible PCB cable) can run through the stent tube 271 (e.g., through the hollow space) from the translation system 300 to the electrodes of the microelectrode probe assembly 600. The electrical connections can electrically couple the electrodes to a pulse generator or controller. For example, a stimulation signal can be delivered to the electrodes for delivery to the tissue surrounding the implanted electrodes. Additionally, recorded signals can be passed from the electrodes to a feedback system of the pulse generator or external data recorder.


With reference to FIGS. 2B and 2C, among others, the microelectrode probe assembly 600 can include four flexible pins 202a, 202b, 202c and 202d (collectively referred to as flexible pins 202). The flexible pins 202 can include a plurality of electrodes 610 disposed along their shafts. The four (or other number) of flexible pins 202 can project in an anterior, posterior, lateral, or medial direction. The flexible pins 202 can be manufactured by laser cutting the distal portion of the stent tube 271. The flexible pins 202 can also be manufactured separately from the stent tube 271 and then coupled, by gluing or laser welding, to the stent tube 271. The separate manufacture of the flexible pins 202 is discussed farther in relation to FIGS. 2D-2E, among others.


The microelectrode probe assembly 600 also includes a central pin 204 along the same longitudinal axis as the inner stent sub-assembly 270. The central pin 204 can be a flattened wire, and in some implementations, can be separate from the flexible pins 202. The central pin 204 can be coupled to the microelectrode probe assembly 600, by gluing or laser welding. The central pin 204 can include a plurality of electrodes 610 disposed along its shaft.


The components of the inner stent sub-assembly 270 can be manufactured from biocompatible materials. In some implementations, the materials are selected to withstand implantation for 24 hours. The material can also be selected such that they remain biocompatible for durations greater than 24 hours. The non-conducting components of the microelectrode probe assembly 600 can be manufactured from polyimide. The conducting components of the microelectrode probe assembly 600 (e.g., the electrodes 610) can be manufactured from platinum, platinum-iridium, and gold, for example.


The microelectrode probe assembly 600, the flexible pins 202, and the electrodes 610 can be sized and shaped for a specified neurological application. For example, the microelectrode probe assembly 600 may be at least partially placed within the central nervous system of a patient or other subject. The microelectrode probe assembly 600 may be placed within other parts or organs of the body, such as the epidural space of the spine, or other locations within the peripheral nervous system, or within an organ such as the liver or heart. The diameter and length of the microelectrode probe assembly 600 and flexible pins 202 may vary depending on the particular anatomical target. In some implementations, there are 2-4, 4-8, 8-12, and 12-16 flexible pins 202. In some implementations, each flexible pins 202 includes 2-4, 4-8, 8-12, 12-16, and 16-32 electrodes 610 per flexible pin 202.


The electrodes 610 can be sized or spaced to record from or stimulate neurons. The microelectrode probe assembly 600 can be used to detect or record neuronal activity at the neurological target. Neuronal activity naturally occurring within the neurological target gives rise to local electromagnetic fields that can be detected by one or more of the microelectrode elements of the microelectrode array. For example, electric fields produced by neurons can polarize one or more of the microelectrode elements. Such polarization gives rise to an electrical potential with respect to a reference, such as electrical ground, or another one of the electrodes 610. The detected electromagnetic fields are conducted from one or more of the electrodes 610 to a device external to the microelectrode device 100. The signals are conducted from the electrode 610 through the internal electrical conductors within the hollow stent tube 271. The external device that is connected to the microelectrode device 100 can be to one or more additional medical devices, which can further processing of the detected electrical activity. For example, the electrodes 610 can be coupled to a display device or recording device for displaying or recording electrical activity from the neurological target.


In some implementations, one or more of the electrodes 610 are used to electrically stimulate a neurological target. For example, one or more externally generated electrical signals can be applied to one or more of electrode 610. These electrical signals can be conducted through the internal electrical conductors to one or more of the electrodes 610. Depending on the amplitude and polarity of the electrical signals, an electrical field can be induced by the polarized electrodes 610. Electrical fields induced by such polarization can interact with one or more neurons at a target site.



FIGS. 2D and 2E illustrate the subcomponents of the microelectrode probe assembly 600. In general the microelectrode probe assembly 600 includes the microelectromechanical systems (MEMS) components and the stent tube 271. FIG. 2D illustrates the MEMS components 620 and 630, and FIG. 2E illustrates the stent tube 271. The MEMS component 630 includes the electrodes for the flexible pins 202. The MEMS component 630 is divided into three regions: the connection array 500, the shoulder 631, and the MEMS legs 605. The MEMS component 620 includes a connection array 500 and a single MEMS leg 605, and is used to create the central pin 204. FIG. 2E illustrates the stent tube 271 before the MEMS components 630 and 620 are added. The connection array 500 includes a plurality of connection pads 510. The connection array 500 can provide a point of connection to each of the electrodes 610 in the microelectrode probe assembly 600.



FIG. 2F illustrates a profile view of an assembled microelectrode probe assembly 600. As illustrated in FIG. 2F, each of the MEMS legs 605 are coupled to, and aligned with, a flexible pin 202. The central MEMS component 620 can be coupled with the central pin 204 and the MEMS main component 630 is wrapped around the distal end of the stent tube 271, such that each MEMS leg 605 aligns with a flexible pins 202 of the stent tube 271. In some implementations, the MEMS components are coupled with the stent tube 271 with a biocompatible adhesive.



FIGS. 2G, 2H, and 2I illustrate a profile, side, and end views, respectively, of a microelectrode probe assembly 600 with foldable extension legs 611. The foldable extension legs 611 (also referred to as MEMS legs 611) extend past the MEMS legs 605 and are then folded along the inner face of each of the flexible pins 202. The each of the foldable extension legs 611 are aligned and coupled with an inner face 612 of one of the flexible pins 202. In this configuration, the microelectrode probe assembly 600 includes electrodes 610 on bath the inner face 612 and outer face 613 of the flexible pins 202. The foldable extension legs 611 are coupled with the MEMS legs 605 by a foldable strip 640 that folds over the distal tip of each of the flexible pins 202.



FIG. 2J illustrate a profile and end view, respectively, of a microelectrode probe assembly 600 with foldable extension legs 611. In the example microelectrode probe assembly 600 of FIGS. 2J and 2H, the foldable strips 640 fold over a side face 641 of each of the flexible pins 202.


Referring to FIG. 2F, among others, each of the MEMS components 620 and 630 include a connection array 500. The connection array 500 can include a plurality of connection pads for establishing an electrical connection with the electrodes disposed on the MEMS components 620 and 630.



FIG. 3A illustrates an enlarged, top-view of an example connection pad 510. FIG. 3B illustrates a side-view of the connection pad 510. Each of the connection pads 510 are electrically coupled with an electrode 610 through an electrical conductor embedded within the polymeric insulation layer 512 MEMS component. A conductive pad 511 is positioned on top of the polymeric insulation layer 512 and over the conductive electrical line embedded within the polymeric insulation layer 512. A through hole 514 is made in the conductive pad 511. Within the through hole 514, a cross-shaped cut 513 is etched through polymeric insulation layer 512. In one embodiment conductive pad 511 is includes gold. The conductive pad 511 can be deposited on the polymeric insulation layer 512 by galvanic deposition onto a platinum layer.



FIGS. 3C and 3D illustrate a side view and top view, respectively, of connection pad 510 with a conductive wire 550 passing through the hole 514 in conductive pad 511. The other end of this electrical conductive wire 550 is connected to an external electronic device or controller. The cross-shaped cut 513 enables that region of polymeric layer 512 to be flexible and temporarily hold the electrical conductive wire 550 in place once it is inserted. In one embodiment the wire can be secured underneath with a non-conductive adhesive. On the surface 551 of the conductive pad 511 a conductive adhesive is used to secure the wire and establish an electrical contact between the wire 550 and conductive pad 511. In some implementations, a PCB cable with via pins is used rather than (or in addition to inserting) conductive wire 550 through the conductive pad 511.



FIGS. 3E, 3F, 3G, and 3H illustrate various views of an example connection array 500 coupled to a flexible PCB cable 560. The flexible PCB cable 560 can include a plurality of via pins 565, which are aligned with the connection pads 510 in the connection array 500. The flexible PCB cable 560 can provide electrical to a plurality of connection arrays 500. The via pins 565 can be inserted through the cross-shaped cut 513 and the through hole 514 in conductive pad 511—similar to how wire 550 was inserted through the through hole 514. An electrical bond between the conductive pad 511 and via pin 565 can be formed through a conductive adhesive. In some implementations, mechanical strength is provided by encapsulating the above described components within a non-conductive adhesive.



FIGS. 3I, 3J, and 3K illustrate various views of coupling the polymeric insulation layer 512 to a flexible cable 560. In FIGS. 3I, 3J, and 3K, the flexible pcb cable 560 is coupled with the polymeric insulation layer 512 using wire-bonding. An electrical connection can be established between two conductive pads 511 (e.g. gold pads) by using a bond wire 1600 (e.g., gold wire about 25 μm in diameter) that is coupled with each of the conductive pads 511. In some implementations, the bond wire 1600 is coupled with the conductive pads 511 using ultrasound vibrations and vertical pressure. The conductive pad 511 of the flexible pcb cable 560 can be accessed through window 1700, which passes through the layers of the polymeric insulation layer 512. The window can be 300 μm×300 μm. In some implementations, the window 1700 is at least 50% larger than the conductive pad 511.



FIGS. 4A and 4B illustrate example views of the tip of an exemplary outer stent sub-assembly 240. The outer stent tube 261 can run the length of the outer stent sub-assembly 240. The outer stent tube 261 can form an elongated shaft. The walls of the outer stent tube 261, as an elongated shaft, can define an internal lumen through which the inner stent sub-assembly 270 can freely slide. The outer stent tube 261 can vary in length and diameter but, for example, can be at least about 28 cm long, (e.g., at least 20 cm long, at least 25 cm long, at least 28 cm long, at least 30 cm long, etc.) and around 1.27 mm in diameter (e.g., in the range of 1.0-2.0 mm in diameter). The internal diameter of the outer stent tube 261 can be slightly larger than the outer diameter of the inner stent sub-assembly 270, such that the inner stent sub-assembly 270 can freely slide within the outer stent tube 261.


An end cap 262 can be coupled to the distal end of the outer stent tube 261. In some implementations, the end cap 262 is coupled to the outer stent tube 261 by gluing or laser welding. At its distal end, the outer wall of the outer stent tube 261 can define four windows 265. The windows 265 can be defined towards the distal end of the outer stent sub-assembly 240. When assembled, one window 265 can align with each of the flexible pins 202. Embodiments with more or fewer flexible pins 202 also include more or fewer, respectively, windows 265 such that each flexible pins 202 is associated with one window 265. The width 241 of each window 265 can be slightly wider (e.g., within 20%) than the width of the flexible pins 202 associated with the window 265.



FIG. 4B illustrates the tip of the outer stent sub-assembly 240 with a protective tube 250 coupled to the outer surface of the outer stent tube 261. A distal end of the protective tube 250 covers a portion of each window 265 and guides each of the flexible pins 202 out of the window 265. In some implementations, the protective tube 250 runs along a substantial portion of the outer stent tube 261. In some embodiments, the protective tube 250 only covers a portion of the outer stent tube 261 near the windows 265.



FIG. 4C illustrates a cross-sectional view of the tip of the outer stent sub-assembly 240. The end cap 262 includes a proximal frustum (or frustoconical shaped end 263, which is coupled within the outer stent sub-assembly 240. The end cap 262 can couple to the outer stent sub-assembly 240 so that the frustum end 263 projects into the internal lumen defined by the walls of the outer stent tube 261. Referring to FIGS. 6A and 6B, among others, the frustum end 263 of the end cap 262 or the protective tube 250, can enable the flexible pins 202 to exit the outer stent sub-assembly 240 at a predetermined trajectory (or angle). The trajectory of the central pin 204 can be controlled by the central channel 267.



FIG. 5A illustrates a perspective view of the tip of the microelectrode device 100 in its undeployed (or default) state. FIG. 5B illustrates a cross-sectional view of the tip of the microelectrode device 100 in its undeployed state. In the undeployed state, each of the flexible pins 202 can be positioned on the frustum end 263 of the end cap 262 and aligned with one of the windows 265. The central pin 204 is aligned with the central channel 267. In the undeployed state, each of the flexible pins 202 can be contained within the outer stent sub-assembly 240 to enable the device to be implanted. Implanting the microelectrode device 100 in the undeployed state provides a smooth exterior profile that can reduce the trauma caused by the microelectrode device 100 as it passes through surrounding tissue en route to the target tissue.



FIGS. 6A and 6B illustrate the tip of the microelectrode device 100 when the microelectrode probe assembly 600 is in its deployed state. The angle 552 of deployment (or exit angle) is defined in part by at least the outer diameter of the microelectrode device 100, the size and shape frustum feature 263 of the end cap 262, and the placement of the protective tube 250. For example, as the inner stent sub-assembly 270 is driven through the outer stent sub-assembly 240, the inward facing side of the flexible pins 202 comes into contact with the frustum feature 263 of the end cap 262. This drives the flexible pins 202 out of the outer stent sub-assembly 240. On their outward facing edge, the flexible pins 202 are guided by the protective tube 250. In some implementations, the frustum feature 263 determines the exit angle 552 of the flexible pins 202 and the protective tube 250 to ensure that the flexible pins 202 do not over extend past the desired exit angle 552. The protective tube 250 can provide the upper limit to the exit angle the flexible pins 202 as the flexible pins exit the windows 265 and the frustum feature 263 of the end cap 262 can provide the minimum exit angle. For example, if the protective tube 250 extends over a larger portion of the windows 265 toward the most distal end of the end cap 262, the exit angle of the flexible pins 202 would be shallower when compared to implementations where the protective tube 250 extends of a smaller portion of the windows 265.



FIGS. 6C-6H illustrate the tip of the microelectrode drive 100 with an independently controllable central pin 204. FIGS. 6C-6H illustrate the deployment of the central pin 204 through the central channel 267 prior to the deployment of the flexible pins 202. In some implementations, the central pin 204 is deployed after the flexible pins 202. In other implementations, only one of the central pin 204 or the flexible pins 202 is deployed.


As illustrated in FIG. 6A, among others, the windows 265 can be slightly wider than the flexible pins 202 (e.g., within 20%). In some implementations, the width 241 of the window 265 is substantially similar to the width of the flexible pins 202 such that the flexible pins 202 can freely exit the outer stent sub-assembly 240, but the windows 265 can control the lateral position of the flexible pins 202 during deployment. For example, the windows 265 reduce unwanted rotation of the flexible pins 202 as they exit the outer stent sub-assembly 240.


In some implementations, the flexible pins 202 and protective tube 250 are configured to reduce delamination of the flexible pins 202 during deployment. Delamination can be caused by friction between the flexible pins 202 and the outer walls of the windows 265. In some implementations, the possibility of delaminating the flexible pins 202 or microelectrode probe assembly 600 is reduced by sliding the flexible pins 202 along the frustum feature 263 and protective tube 250 rather than the walls of the windows 265. The protective tube 250 can be made out of a polymeric material that is the same or similar to the material used to manufacture the microelectrode probe assembly 600 or the flexible pins 202. The material can be selected to reduce the friction between the protective tube 250 and the frustum feature 263. The protective tube 250 and the frustum feature 263 can be manufactured to reduce abrasion during the deployment of the flexible pins 202 when compared to a device without a protective tube 250. In some implementations, the coefficient of friction of the flexible pins 202 against the protective tube 250 or the frustum feature 263 is between about 0.5 and about 0.01, between about 0.3 and about 0.01, or less than about 0.1. The coefficient of friction of the flexible pins 202 rubbing against the protective tube 250 constructed from a polyimide material may be about half as much when compared to a device where the flexible pins 250 rub against a stainless steel shaft. In some implementations, the coefficient of friction between the flexible pins 202 and the protective tube 250 is achieved because the outer faces of the flexible pins 202 and the protective tube 250 include the same substrate material, such as a polymeric material.


In some implementations, the protective tube 250 and the frustum feature 263 are manufactured from the same material as the flexible pins 202 to limit delamination. For example, the protective tube 250, the flexible pins 202, or the frustum feature 263 can be manufactured from polyimide. In some implementations, the selected material has a low coefficient of friction (COF). For example, the selected material can have a COF less than 0.5, less than 0.2, or less than 0.1. The relatively low COF enables the flexible pins 202 to smoothly slide out of the outer stent sub-assembly 240 during deployment. A low COF reduces the risk of delamination by reducing the force applied to the flexible pins 202 as they exit the outer stent sub-assembly 240.



FIGS. 6A and 6B, FIGS. 6I and 6J, among others, illustrate the deployment of the microelectrode probe assembly 600. In some implementations, as illustrated in FIG. 6I, the central pin 204 is fixed in the deployed state. The deployed central pin 204 can reduce tissue coring, a process by which the central channel 267 (without the central pin 204 deployed) can cut through tissue. To reduce the likelihood of coring, the central pin 204 can be fixed in the deployed state and any gap between the central channel 267 and the central pin 204 can be filled. In some implementations, the filling forms a cone-like transition between the base of the central pin 204 and the central channel 267. In some implementations, recording can be made with the central pin 204 during the implantation process to, for example, determine the position of the microelectrode probe assembly 600. FIG. 6J illustrates the deployment of the flexible pins 202, which does not change the position of the central pin 204.



FIG. 7A illustrates a side view of an exemplary translation system 300, and FIG. 7B illustrates a cross-sectional view of the translation system 300. The translation system 300 can drive the inner stent sub-assembly 270 through the outer stent sub-assembly 240 to deploy and retract the flexible pins 202. As described in relation to FIG. 1, the translation system 300 is coupled to the proximal end of the lead assembly 105. As illustrated in FIG. 7A, the housing of the controller 300 includes a translator ring 311, a removable end cap 310, and a main body housing 312.


Referring to FIG. 7B, the internal components of the translation system 300 include a locking pin 313, a translator rod 330, and guide pins 320. In some implementations, the translation system 300 drives the inner stent sub-assembly 270 by converting a rotational movement of the translator ring 311 into an axial movement of the translator rod 330 along the length of the microelectrode device. The translator ring 311 and the translator rod 330 can act as a lead screw to axially drive the translator rod 330 and the inner stent sub-assembly 270. The internal bore of the translator ring 311 can include a thread that mates with threads on the translator rod 330. As an operator rotates the translator ring 311, the threads of the translator ring 311 impart a force on the threads of the translator rod 330 and an axial movement is induced on the translator rod 330. The translator rod 330 can be coupled with the inner stent sub-assembly 270 of the probe assembly 600 by laser welding or gluing. In some implementations, the translator rod 330 is coupled within the translation system 300 such that it only has one degree of movement along the central axis of the translation system 300.


In some implementations, the controller does not have a translator ring 311, but rather the flexible pins 202 are deployed using a push-pull rod. For example, the push-pull rod can be coupled to the inner stent sub-assembly 270 along its linear axis. As an operator pushes or pulls the push-pull rod, the motion is directly translated to the inner stent sub-assembly 270 and the flexible pins 202.


The translation system 300 includes a removable back cap 310. Removing the back cap 310 provides access to the inner stent sub-assembly 270. The back cap 310 can be unscrewed by hand or with a tool. In some implementations, the translator ring 311 can also be removed from the translation system 300 after removal of the back cap 310. After removal of the back cap 310 and the translator ring 311, an operator is provided adequate access to remove the translator rod 330 and the inner stent sub-assembly 270. In some implementations, the removal of the back cap 310 is a safety mechanism that enables an operator to expose the internal components of the microelectrode device 100 and retract the inner stent sub-assembly 270 and flexible pins 202 in the event of a mechanical failure within the translation system 300. The method of dismantling the translation system 300 is described further in relation to FIGS. 9A-9E.


The translation system 300 can include a centering pin 321 and one or more guide pins 320. In some implementations, the centering pin 321 is used to index the microelectrode device 100 in a stereotactic apparatus (e.g., a stereotactic apparatus used in deep brain stimulation surgery). For example, the centering pin 321 and the guide pins 320 may be placed in a vertical arrangement within the stereotactic apparatus to indicate the initial position of the microelectrode device 100 relative to the stereotactic apparatus. In some implementations, the guide pins 320 form a key that can mate with a lock on a stereotactic apparatus. The guide pins 320 prevent any rotational movement that may be induced when using translator ring 311 and also assist with the initial indexing of the microelectrode device 100 to the stereotactic apparatus.


In some implementations, the centering pin 321 also reinforces the portion of the outer stent sub-assembly 240 where the microelectrode device 100 is typically clamped to the stereotactic apparatus. In some implementations, guide pins 320 are separated from one another (as measured by the distance between their longitudinal axes) by about 4 mm. In some implementations, each guide pin 320 is spaced (as measured by the distance between their longitudinal axes) about 2 mm from the centering pin 321. The interaction of the translation system 300 with the stereotactic apparatus is discussed further in relation to FIGS. 9A-9E.



FIG. 7C illustrates a cross-sectional view of the example translation system 300, and FIG. 7D illustrates an exploded view of the translation system 300. The translation system 300 includes guiding and indexing features for the deployment of the flexible pins 202. The translation system 300 includes a translator rod 330, which translates the rotation of the translator ring 311 into a linear movement along the central axis of the translation system 300. The translation system 300 also includes a plurality of ball (or other type of) bearings 432 that are held against the translator main body 312 by springs 431. The ball bearings 432 and springs 431 can be part of the indexing system. The translator rod 330 can include guiding structures 331 that fit into guiding slits 411 of the guiding tube 410. The guiding tube 410 can be inserted and fixed into the translator main body 312.



FIG. 7E illustrates additional detail about the translation system 300. The outer stent sub-assembly 240 can be coupled with the main body housing 312. The above described outer stent sub-assembly 240 can be coupled with the translation system 300, for example by inserting the outer stent sub-assembly 240 into the centering pin 321. In some implementations, the outer stent sub-assembly 240 is coupled to the centering pin 321 by laser welding or gluing. The controller 300 can include at least two mechanical stops 407. The first can be the default, undeployed position as illustrated in FIGS. 5A and 5B, and the second can be the fully deployed position as illustrated in FIGS. 6A and 6B. Mechanical stop 470a can be encountered when the translator rod 330 is in contact with main body 312. Mechanical stop 470b can be encountered when the translator rod 330 is fully in contact with locking pin 313. In some implementations, the first mechanical stop can ensure the flexible pins 202 are not over-retracted within the outer stent sub-assembly 240. The second mechanical stop can ensure the flexible pins 202 are not over deployed. In some implementations, the second mechanical stop enables the flexible pins 202 to be deployed to a length of about 10 mm-8 mm, about 8 mm-6 mm, about 6 mm-4 mm, or about 4 mm-2 mm. The translation system 300 can include a plurality of intermediate steps, which allow the flexible pins 202 to be deployed a predetermined distance less than their fully deployed length.



FIG. 7F is a side view of the translator rod 330 and guiding tube 410, when the translator rod 330 is inserted into the guiding tube 410 and illustrated without the other components of the translation system 300. The guiding slits 411 of the guiding tube 410 can provide the translator rod 330 one degree of freedom, e.g., along the central axis of the translation system 300. In the example translation system 300, the guiding tube 410 can include three guiding slits 411, and the translator rod 330 includes three guiding structure 331. The guiding structures 331 slide into the guiding slits 411. Insertion of the guiding structures 331 into the guiding slits 411 can prevent the translator rod 330 from substantially rotating, and can limit the translator rod's movement to a single degree of freedom.



FIGS. 7G, 7H, 7I, and 7J provide additional images of how the guiding structures 331 move along the guiding tube 410 as the user rotates the translator ring 311. FIG. 7G represents the default state of the translation system 300. In FIG. 7I the translator ring 311 is hidden to illustrate that in the default state of the translation system 300, the translator rod 330 is toward the proximal end of the translation system 300. As the user rotates the translator ring 311 (as illustrated in FIG. 7H), the translator rod 330 is advanced, deploying the flexible pins 202. FIG. 7J illustrates the translation system 300 without the translator ring 311 to show that in the deployed state the translator rod 330 is in a position toward the distal end of the translation system 300.


The translation system 300 includes an indexing system to enable an operator to deploy the flexible pins 202 to predetermined lengths. FIG. 8A illustrates a side view of a partially constructed translation system 300, and FIG. 8B illustrates a cut away along plain 700 of the partially constructed translation system 300. In FIG. 8A, the translator ring 311 is pulled away from the translator main body 312 to expose the ball bearings 432 and springs 431 of the indexing system (collectively referred to as ball bearing-springs 433). The indexing system allows for control of the translator rod 330 between the undeployed and deployed state of the flexible pins 202. The indexing system enables a user to determine if the flexible pins are deployed, retracted, or at predetermined positioned therebetween.



FIG. 8B illustrates the back face 701 of the translator main body 312. The indexing system includes the ball bearing-springs 433 and indexing holes 314a and 314b. The ball bearing-spring system 433 is composed of ball bearings 432 of a diameter of 1 mm and a spring 431. The spring 431 holds the ball bearings 432 against the back face 701 of the translator main body 312. These springs 431 can be received by holes drilled into the translator ring 311. The indexing holes 314 can be semi-hemispherical holes milled into the back face 701 of the translator main body 312. The diameter of the indexing holes 314 can be approximately (e.g., +/−10%) the same diameter of the ball bearings 432, such that the indexing holes 314 can receive the ball bearings 432. As the translator ring 311 is rotated the ball bearings 432 fall into the indexing holes 314 to indicate predetermined amounts of deployment of the flexible pins 202. In some implementations, the ball bearing-spring system 433 reduces mechanical play that may be present in mechanical translation system 300. For example, the ball bearing-spring system 433 can provide a mechanical stability feature (e.g., a three contact point system) that can reduce the friction between the translator ring 311 and the translator main body 312.


The distance from the central axis of the translation system 300 can be different for one or more of the ball bearing-spring system 433. For example, FIG. 8B depicts ball bearing-spring systems 433a and 433b that can be radially offset to a slightly different difference than ball bearing-spring 433c. In this example, ball bearing-spring 433c is used in the indexing system while the ball bearing-springs 433a and 433b are used for mechanical stability. The indexing holes 314 can be offset the same distance from the central axis of the translation system 300 as the ball bearing-spring 433c. For example, when indexing hole 314a receives the ball bearings 432 of ball bearing-spring 433c the flexible pins 202 are fully retracted and when the translator ring 311 is rotated such that the indexing hole 314b receives the ball bearings 432 of ball bearing-spring 433c the flexible pins 202 are fully deployed. In some implementations, a plurality of indexing holes are placed along the radial path between indexing hole 314a and indexing hole 314b such that the flexible pins 202 may be deployed to specific lengths. The length of the track virtually drawn along that particular radius defines the maximum linear travel distance induced on translator rod 330. FIGS. 8C, 8D, 8E, 8F, and 8G illustrate how the translator ring 311, ball bearing-springs 433, and the other components of the indexing system fit together.



FIGS. 9A-9E illustrate an example of the systematic disassembling of the translation system 300. The translation system 300 can be disassembled as a safety mechanism to retract the flexible pins 202 if the translation system 300 becomes stuck. In some implementations, first, the removable end cap 310 is removed to reveal the locking pin 313 and the guiding tube 410. Next, the locking pin 313 is removed and then the guiding tube 410. Then, the translator rod 330 is removed to reveal the inner stent sub-assembly 270, which an operator may remove by hand to retract the flexible pins 202.


In some implementations, one or more of the flexible pins 202 are independently controllable. The translation system 300 can include different translator rings 311 to control the deployment of each of the independently controllable flexible pins 202. FIG. 10A illustrates a perspective view of a translation system 300 with two translator rings 311. FIG. 10B illustrates a side view of the translation system 300 with two translator rings 311. The translation system 300 with two translator rings 311 could be used, for example, to control a microelectrode device with an independently controlled central pin. For example, the first translator ring 311 could be used to control the deployment of the central pin and the second translator ring 311 could be used to control the deployment of the remaining flexible pins.



FIGS. 10C and 10D illustrate perspective and side views, respectively, or a translation system 300 with five translator rings 311. In some implementations, each of the flexible pins of the microelectrode device can be independently controlled. Accordingly, each of the flexible pins of the microelectrode device can be coupled to one of the five translator rings 311 to enable independent deployment and retraction of the flexible pins. In some implementations with independently deployable flexible pins, the surgeon could deploy only the flexible pins that are of diagnostic interest during a surgical procedure, and avoid deploying the flexible pins that may cause patient harm.



FIGS. 11A and 11B illustrate how the translation system 300 interacts with an example stereotactic apparatus 800. The holding piece 810 of the apparatus 800 includes a plurality of mating holes 815. The holes 815 are configured to mate with the guide pins 320 of the translation system 300. Once the guide pins 320 are mated with the holes 815, as illustrated in FIG. 11B, among other, the translation system 300 cannot rotate around its central axis.



FIG. 11C illustrates microelectrode device 100 in use with a stereotactic frame 1200. The stereotactic frame 1200 can be placed and fixed to the patient's head prior surgery. The caliper device 800 can be part of the stereotactic frame 1200 and can be used to interface with the microelectrode device 100 and can determine the microelectrode device's location relative to the patient's head. The insertion trajectory of the device 100 can be guided using a guiding tube 1210 which can interface with stereotactic apparatus 800 through the holding piece 810. With the microelectrode device 100 at a desired location, the pins can be deployed as illustrated in FIG. 11C.


In some implementations, the microelectrode device is configured to prevent extraction of the electrode device while the flexible pins are deployed into a patients tissue. In some implementations, the translation system 300 of the microelectrode device includes alarms to alert the surgeon when the flexible pins are deployed or a mechanism that prevents removal of the microelectrode device when the flexible pins are deployed.


The translation system 300 can include a visual or an audible alarm system such as LEDs or buzzers. When the flexible pins are in their retracted state, the alarm can be off. When one of the flexible pins is deployed, the alarm can activate. For example, when the flexible pins are retracted a red LED on the translation system 300 may be off. However, when one of the flexible pins are deployed power may be provided to the red LED to alert the surgeon that he should not remove the microelectrode device from the patient. The translation system 300 can include a second LED, such as a green LED, that indicates to the surgeon that the flexible pins are retracted and it is safe to remove the microelectrode device from the patient. The alarm can be powered by battery resident within the translation system 300.


The visual alarm of the translation system 300 can include a mechanical indicator which exposes a colored ring, or other static visible indicator, when one or more flexible pins are deployed. This visible indicator can remain visible until each of the flexible pins are retracted. The mechanical indicator may not require a power source to generate the alert to the surgeon.


The translation system 300 can physically prevent the removal of the microelectrode device form the patient when one or more flexible pins are deployed. FIG. 12 illustrates the interaction of the translation system 300 and a portion of a stereotactic frame 800 to prevent removal of the microelectrode device.


In some implementations, a portion of the stereotactic frame 800 can be electrically or mechanically connected to the translation system 300 to prevent the displacement of the microelectrode device in certain conditions, such as when the flexible pins are deployed. The stereotactic frame 800 could electrically, or mechanically, block the movement of the microelectrode device with respect to the patient's brain, if the flexible pins are not in a safe position.



FIG. 12 illustrates an example mechanical system for preventing the retraction of the microelectrode device when one or more flexible pins are deployed. A blocking mechanism 801 can be coupled to the translation system 300. The blocking mechanism includes a rotary extension 805. As one of the translation rings 311 are rotated to deploy one or more of the flexible pins, gears within the rotary extension 805 can rotate a blocking extension 515 over a lip of a holding piece 810. For example, if the surgeon attempted to retract the microelectrode device by pulling the translation system 300, the blocking extension 515 would hold the microelectrode device in place. With the flexible pins retracted, the blocking extension 515 would not catch the holding piece 810 and the microelectrode device could be withdrawn from the patient.


Various implementations of the microelectrode device have been described herein. These embodiments are giving by way of example and not to limit the scope of the present disclosure. The various features of the embodiments that have been described may be combined in various ways to produce numerous additional embodiments. Moreover, while various materials, dimensions, shapes, implantation locations, etc. have been described for use with disclosed embodiments, others besides those disclosed may be utilized without exceeding the scope of the disclosure.


Devices described herein as either acute or chronic may be used acutely or chronically. They may be implanted for such periods, such as during a surgery, and then removed. They may be implanted for extended periods, or indefinitely. Any devices described herein as being chronic may also be used acutely.


The present disclosure is not to be limited in terms of the particular embodiments described in this application, which are intended as illustrations of various aspects. Modifications and variations can be made without departing from its spirit and scope of this disclosure. Functionally equivalent methods and apparatuses may exist within the scope of this disclosure. Such modifications and variations are intended to fall within the scope of the appended claims. The subject matter of the present disclosure includes the full scope of equivalents to which it is entitled. This disclosure is not limited to particular methods, reagents, compounds compositions or biological systems, which can vary. The terminology used herein is for the purpose of describing particular embodiments, and is not intended to be limiting.


With respect to the use of substantially any plural or singular terms herein, the plural can include the singular or the singular can include the plural as is appropriate to the context or application.


In general, terms used herein, and especially in the appended claims (e.g., bodies of the appended claims) are generally intended as “open” terms (e.g., the term “including” should be interpreted as “including but not limited to,” the term “having” should be interpreted as “having at least,” the term “includes” should be interpreted as “includes but is not limited to,” etc.). Claims directed toward the described subject matter may contain usage of the introductory phrases “at least one” and “one or more” to introduce claim recitations. However, the use of such phrases should not be construed to imply that the introduction of a claim recitation by the indefinite articles “a” or “an” limits any particular claim containing such introduced claim recitation to embodiments containing only one such recitation, even when the same claim includes the introductory phrases “one or more” or “at least one” and indefinite articles such as “a” or “an” (e.g., “a” and/or “an” should be interpreted to mean “at least one” or “one or more”); the same holds true for the use of definite articles used to introduce claim recitations. In addition, even if a specific number of an introduced claim recitation is explicitly recited, such recitation can mean at least the recited number (e.g., the bare recitation of “two recitations,” without other modifiers, means at least two recitations, or two or more recitations). Furthermore, in those instances where a convention analogous to “at least one of A, B, and C, etc.” is used, in general such a construction would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and/or A, B, and C together, etc.). In those instances where a convention analogous to “at least one of A, B, or C, etc.” is used, in general such a construction would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and/or A, B, and C together, etc.). Any disjunctive word or phrase presenting two or more alternative terms, whether in the description, claims, or drawings, can contemplate the possibilities of including one of the terms, either of the terms, or both terms. For example, the phrase “A or B” includes the possibilities of “A” or “B” or “A and B.”


In addition, where features or aspects of the disclosure are described in terms of Markush groups, the disclosure is also described in terms of any individual member or subgroup of members of the Markush group.


Any ranges disclosed herein also encompass any and all possible subranges and combinations of subranges thereof. Any listed range can be easily recognized as sufficiently describing and enabling the same range being broken down into at least equal halves, thirds, quarters, fifths, tenths, etc. As a non-limiting example, each range discussed herein can be readily broken down into a lower third, middle third and upper third, etc. Language such as “up to,” “at least,” “greater than,” “less than,” and the like include the number recited and refer to ranges which can be subsequently broken down into subranges as discussed above. Finally, a range includes each individual member.


One or more or any part thereof of the techniques described herein can be implemented in computer hardware or software, or a combination of both. The methods can be implemented in computer programs using standard programming techniques following the method and figures described herein. Program code is applied to input data to perform the functions described herein and generate output information. The output information is applied to one or more output devices such as a display monitor. Each program may be implemented in a high level procedural or object oriented programming language to communicate with a computer system. However, the programs can be implemented in assembly or machine language, if desired. In any case, the language can be a compiled or interpreted language. Moreover, the program can run on dedicated integrated circuits preprogrammed for that purpose.


Each such computer program can be stored on a storage medium or device (e.g., ROM or magnetic diskette) readable by a general or special purpose programmable computer, for configuring and operating the computer when the storage media or device is read by the computer to perform the procedures described herein. The computer program can also reside in cache or main memory during program execution. The analysis, preprocessing, and other methods described herein can also be implemented as a computer-readable storage medium, configured with a computer program, where the storage medium on configured causes a computer to operate in a specific and predefined manner to perform the functions described herein. In some embodiments, the computer readable media is tangible and substantially non-transitory in nature, e.g., such that the recorded information is recorded in a form other than solely as a propagating signal.


In some embodiments, a program product may include a signal bearing medium. The signal bearing medium may include one or more instructions that, when executed by, for example, a processor, may provide the functionality described above. In some implementations, signal bearing medium may encompass a computer-readable medium, such as, but not limited to, a hard disk drive, a Compact Disc (CD), a Digital Video Disk (DVD), a digital tape, memory, etc. In some implementations, the signal bearing medium may encompass a recordable medium, such as, but not limited to, memory, read/write (R/W) CDs, R/W DVDs, etc. In some implementations, signal bearing medium may encompass a communications medium such as, but not limited to, a digital or an analog communication medium (e.g., a fiber optic cable, a waveguide, a wired communications link, a wireless communication link, etc.). Thus, for example, the program product may be conveyed by an RF signal bearing medium, where the signal bearing medium is conveyed by a wireless communications medium (e.g., a wireless communications medium conforming with the IEEE 802.11 standard).


Any of the signals and signal processing techniques may be digital or analog in nature, or combinations thereof.


While certain embodiments of this disclosure have been particularly shown and described with references to preferred embodiments thereof, various changes in form and details may be made therein without departing from the scope of the disclosure.

Claims
  • 1. An implantable microelectrode device, comprising: an elongated shaft having an outer wall and a distal end, the outer wall of the elongated shaft defining an internal lumen, the outer wall of the elongated shaft defining a plurality of windows toward the distal end;an end cap coupled with the distal end of the elongated shaft, the end cap defining a central channel, the end cap having a frustum end, the frustum end defining a projection into the internal lumen of the elongated shaft;a protective tube coupled with an outer surface of the elongated shaft and covering a portion of each of the plurality of windows; anda probe assembly to slide through the internal lumen of the elongated shaft, the probe assembly comprising: a central pin configured for deployment via the central channel;a plurality of flexible pins, each of the plurality of flexible pins configured for deployment through a corresponding window of the plurality of windows via sliding through the internal lumen, the deployment of each of the plurality of flexible pins through the corresponding window at an exit angle defined at least in part by the projection of the frustum end of the end cap into the internal lumen and a placement of a distal end of the protective tube over the corresponding window, the deployment of each of the plurality of flexible pins through the corresponding window independent of the deployment of the central pin via the central channel; andmicroelectromechanical system (MEMS) components having a first MEMS component disposed on the central pin and a second MEMS component disposed on one or more of the plurality of flexible pins.
  • 2. The device of claim 1, comprising: the plurality of flexible pins configured to slide through the corresponding window.
  • 3. The device of claim 1, comprising: the second MEMS component comprises a first plurality of MEMS legs, each of the first plurality of MEMS legs aligned and coupled with an outer face of one of the plurality of flexible pins.
  • 4. The device of claim 3, comprising: a second plurality of MEMS legs coupled to the first plurality of MEMS legs by a foldable strip, each of the second plurality of MEMS legs aligned and coupled with an inner face of one of the plurality of flexible pins.
  • 5. The device of claim 3, each of the first plurality of MEMS legs comprising at least one electrode.
  • 6. The device of claim 1, comprising: the protective tube including a polymeric material.
  • 7. The device of claim 1, comprising: a material of the protective tube having a coefficient of friction between about 0.5 and about 0.01 with respect to the plurality of flexible pins.
  • 8. The device of claim 1, comprising: a material of the protective tube having a coefficient of friction between about 0.2 and about 0.01 with respect to the plurality of flexible pins.
  • 9. The device of claim 1, comprising: the protective tube and the plurality of flexible pins made of a same substrate material.
  • 10. The device of claim 1, wherein a minimum of the exit angle is defined by the frustum of the end cap and a maximum of the exit angle is defined by the distal end of the protective tube.
  • 11. The device of claim 1, wherein the plurality of windows in the outer wall of the elongated shaft include at least four windows.
  • 12. The device of claim 1, comprising: a translation system comprising a translation ring and a translator rod, the translation system configured to convert a rotational movement of the translation ring into an axial movement of the translator rod.
  • 13. The device of claim 12, comprising: the translator rod coupled with the probe assembly.
  • 14. The device of claim 12, comprising: a second translation ring configured to convert a rotational movement of the second translation ring into an axial movement to deploy the central pin through the central channel of the end cap.
  • 15. The device of claim 1, comprising: an alarm configured to indicate when at least one of the plurality of flexible pins is deployed.
  • 16. A method of obtaining neurological activity information, comprising: implanting microelectrode device within a vicinity of a neurological target, the microelectrode device comprising: an elongated shaft having an outer wall and a distal end, the outer wall of the elongated shaft defining an internal lumen, the outer wall of the elongated shaft defining the outer wall defining a plurality of windows;an end cap coupled with the distal end of the elongated shaft, the end cap defining a central channel, the end cap having a frustum end, the frustum end defining a projection into the internal lumen of the elongated shaft;a protective tube coupled with an outer surface of the elongated shaft and covering a portion of each of the plurality of windows; anda probe assembly to slide through the internal lumen of the elongated shaft, the probe assembly comprising microelectromechanical system (MEMS) components, a central pin, a plurality of flexible pin, the MEMS components having a first MEMS component disposed on the central pin and a second MEMS component disposed on one or more of the plurality of flexible pins each of the plurality of flexible pins comprising a plurality of electrode sites; anddeploying at least one of the central pin through the central channel or the plurality of flexible pins through a corresponding window of the plurality of windows via sliding through the internal lumen, the deployment of each of the plurality of flexible pins through the corresponding window at an exit angle defined at least in part by the projection of the frustum end of the end cap into the internal lumen and a placement of a distal end of the protective tube over the corresponding window, the deployment of each of the plurality of flexible pins through the corresponding window independent of the deployment of the central pin through the central channel.
  • 17. The method of claim 16, comprising: coupling the microelectrode device with a stereotactic apparatus.
  • 18. The method of claim 16, further comprising: rotating a first translator ring of the microelectrode device to deploy at least one of the plurality of flexible pins through a different one of the plurality of windows.
  • 19. The method of claim 18, further comprising: rotating a second translator ring of the microelectrode device to deploy the central pin through the central channel of the end cap.
  • 20. The method of claim 16, further comprising: retracting at least one of the plurality of flexible pins through the different one of the plurality of windows.
  • 21. The method of claim 16, further comprising: coupling the microelectrode device to a neural recording and neurostimulation device; andrecording neurological activity using the plurality of electrode sites.
  • 22. The method of claim 16, comprising: sliding the plurality of flexible pins along the frustum end of the end cap and the distal end of the protective tube.
  • 23. The method of claim 16, wherein a minimum of the exit angle is defined by the frustum of the end cap and a maximum of the exit angle is defined by the distal end of the protective tube.
  • 24. The method of claim 16, wherein the plurality of windows in the outer wall of the elongated shaft include at least four windows.
RELATED APPLICATIONS

The present application is a national stage application, filed under 35 U.S.C. § 371, of PCT Application No. PCT/IB2015/053610, filed May 15, 2015, entitled “DEVICE FOR INTERACTING WITH NEUROLOGICAL TISSUE AND METHODS OF MAKING AND USING THE SAME,” which claims priority to U.S. Application No. 61/994,359, filed May 16, 2014, all of which are hereby incorporated by reference in their entireties.

PCT Information
Filing Document Filing Date Country Kind
PCT/IB2015/053610 5/15/2015 WO 00
Publishing Document Publishing Date Country Kind
WO2015/173787 11/19/2015 WO A
US Referenced Citations (818)
Number Name Date Kind
4245645 Arseneault et al. Jan 1981 A
4550733 Liss et al. Nov 1985 A
4837049 Byers et al. Jun 1989 A
4917093 Dufresne et al. Apr 1990 A
4928297 Tsutsui et al. May 1990 A
4969468 Byers et al. Nov 1990 A
4989617 Memberg et al. Feb 1991 A
5095905 Klepinski Mar 1992 A
5215088 Normann et al. Jun 1993 A
5391250 Cheney et al. Feb 1995 A
5400784 Durand et al. Mar 1995 A
5419777 Hofling May 1995 A
5458629 Baudino et al. Oct 1995 A
5496369 Howard, III Mar 1996 A
5524338 Martyniuk et al. Jun 1996 A
5628317 Starkebaum et al. May 1997 A
5643330 Holsheimer et al. Jul 1997 A
5679355 Alexander et al. Oct 1997 A
5683422 Rise Nov 1997 A
5697651 Fernandes Dec 1997 A
5697975 Howard et al. Dec 1997 A
5702429 King Dec 1997 A
5713922 King Feb 1998 A
5713923 Ward et al. Feb 1998 A
5716377 Rise et al. Feb 1998 A
5727552 Ryan Mar 1998 A
5752979 Benabid May 1998 A
5755759 Cogan May 1998 A
5782798 Rise Jul 1998 A
5797970 Pouvreau Aug 1998 A
5800474 Benabid et al. Sep 1998 A
5800535 Howard, III Sep 1998 A
5814092 King Sep 1998 A
5824029 Weijand et al. Oct 1998 A
5792186 Rise Nov 1998 A
5833709 Rise et al. Nov 1998 A
5833714 Loeb Nov 1998 A
5843148 Gijsbers et al. Dec 1998 A
5893883 Torgerson et al. Apr 1999 A
5913882 King Jun 1999 A
5921924 Avitall Jul 1999 A
5927277 Baudino et al. Jul 1999 A
5941906 Barreras et al. Aug 1999 A
5957958 Schulman et al. Sep 1999 A
5975085 Rise Nov 1999 A
5978702 Ward et al. Nov 1999 A
5991668 Leinders et al. Nov 1999 A
6011996 Gielen et al. Jan 2000 A
6018682 Rise Jan 2000 A
6024095 Stanley, III Feb 2000 A
6033403 Tu et al. Mar 2000 A
6038480 Hrdlicka et al. Mar 2000 A
6050992 Nichols Apr 2000 A
6094598 Elsberry et al. Jul 2000 A
6104960 Duysens et al. Aug 2000 A
6109269 Rise et al. Aug 2000 A
6125300 Weijand et al. Sep 2000 A
6128537 Rise Oct 2000 A
6129685 Howard, III Oct 2000 A
6161047 King et al. Dec 2000 A
6205359 Boveja Mar 2001 B1
6205361 Kuzma et al. Mar 2001 B1
6216043 Swanson et al. Apr 2001 B1
6227203 Rise et al. May 2001 B1
6253109 Gielen Jun 2001 B1
6253110 Brabec et al. Jun 2001 B1
6263237 Rise Jul 2001 B1
6266564 Hill et al. Jul 2001 B1
6295476 Schaenzer Sep 2001 B1
6301492 Zonenshayn Oct 2001 B1
6319241 King et al. Nov 2001 B1
6330466 Hofmann et al. Dec 2001 B1
6337997 Rise Jan 2002 B1
6343226 Sunde et al. Jan 2002 B1
6353762 Baudino et al. Mar 2002 B1
6356784 Lozano et al. Mar 2002 B1
6356786 Rezai et al. Mar 2002 B1
6356787 Rezai et al. Mar 2002 B1
6364875 Stanley, III Apr 2002 B1
6366813 DiLorenzo Apr 2002 B1
6374140 Rise Apr 2002 B1
6375666 Mische Apr 2002 B1
6379353 Nichols Apr 2002 B1
6415187 Kuzma et al. Jul 2002 B1
6434431 Camps et al. Aug 2002 B1
6459936 Fischell et al. Oct 2002 B2
6479999 Demeester et al. Nov 2002 B1
6484059 Gielen Nov 2002 B2
6493590 Wessman et al. Dec 2002 B1
6510347 Borkan Jan 2003 B2
6529774 Greene Mar 2003 B1
6538443 Morich et al. Mar 2003 B2
6549812 Smits Apr 2003 B1
6556873 Smits Apr 2003 B1
6560472 Hill et al. May 2003 B2
6560486 Osorio et al. May 2003 B1
6581046 Ahissar Jun 2003 B1
6587733 Cross et al. Jul 2003 B1
6591128 Wu et al. Jul 2003 B1
6594524 Esteller et al. Jul 2003 B2
6597953 Boling Jul 2003 B2
6643552 Edell et al. Nov 2003 B2
6671544 Baudino Dec 2003 B2
6675046 Holsheimer Jan 2004 B2
6687538 Hrdlicka et al. Feb 2004 B1
6690973 Hill et al. Feb 2004 B2
6708064 Rezai Mar 2004 B2
6718208 Hill et al. Apr 2004 B2
6718211 Smits Apr 2004 B2
6741893 Smits May 2004 B2
6745079 King Jun 2004 B2
6757970 Kuzma et al. Jul 2004 B1
6795737 Gielen et al. Sep 2004 B2
6804552 Thompson et al. Oct 2004 B2
6818396 Bloch et al. Nov 2004 B1
6829498 Kipke et al. Dec 2004 B2
6850802 Holsheimer Feb 2005 B2
6871098 Nuttin et al. Mar 2005 B2
6882881 Lesser et al. Apr 2005 B1
6892097 Holsheimer May 2005 B2
6892438 Hill et al. May 2005 B1
6904306 Wu et al. Jun 2005 B1
6909920 Lokhoff et al. Jun 2005 B2
6920359 Meadows et al. Jul 2005 B2
6928320 King Aug 2005 B2
6950706 Rodriguez et al. Sep 2005 B2
6950709 Baudino Sep 2005 B2
6978171 Goetz et al. Dec 2005 B2
6978178 Sommer et al. Dec 2005 B2
6999819 Swoyer et al. Feb 2006 B2
7006859 Osorio et al. Feb 2006 B1
7010351 Firlik et al. Mar 2006 B2
7010356 Jog et al. Mar 2006 B2
7024246 Acosta et al. Apr 2006 B2
7035690 Goetz Apr 2006 B2
7047082 Schrom et al. May 2006 B1
7047084 Erickson et al. May 2006 B2
7050856 Stypulkowski May 2006 B2
7051419 Schrom et al. May 2006 B2
7061240 Ham et al. Jun 2006 B2
7063767 Tyson et al. Jun 2006 B1
7076292 Forsberg Jul 2006 B2
7077822 Howard, III Jul 2006 B1
7107104 Keravel et al. Sep 2006 B2
7133718 Bakken et al. Nov 2006 B2
7146222 Boling Dec 2006 B2
7151961 Whitehurst et al. Dec 2006 B1
7174219 Wahlstrand et al. Feb 2007 B2
7177701 Pianca Feb 2007 B1
7181288 Rezai et al. Feb 2007 B1
7184829 Hill et al. Feb 2007 B2
7187978 Malek et al. Mar 2007 B2
7191016 Marshall et al. Mar 2007 B2
7191018 Gielen et al. Mar 2007 B2
7198626 Lee Apr 2007 B2
7200439 Zdeblick et al. Apr 2007 B2
7203548 Whitehurst et al. Apr 2007 B2
7204798 Zdeblick et al. Apr 2007 B2
7204833 Osorio et al. Apr 2007 B1
7209787 DiLorenzo Apr 2007 B2
7212851 Donoghue et al. May 2007 B2
7212867 Van Venrooij et al. May 2007 B2
7214189 Zdeblick May 2007 B2
7216000 Sieracki et al. May 2007 B2
7216001 Hacker et al. May 2007 B2
7231256 Wahlstrand et al. Jun 2007 B2
7236822 Dobak, III Jun 2007 B2
7242984 DiLorenzo Jul 2007 B2
7276061 Schaer et al. Oct 2007 B2
7280867 Frei et al. Oct 2007 B2
7282030 Frei et al. Oct 2007 B2
7282050 Starkebaum et al. Oct 2007 B2
7286878 Stypulkowski Oct 2007 B2
7286882 Cole Oct 2007 B2
7288066 Drew Oct 2007 B2
7289851 Gunderson et al. Oct 2007 B2
7289852 Helfinstine et al. Oct 2007 B2
7295880 Gielen Nov 2007 B2
7298143 Jaermann et al. Nov 2007 B2
7307223 Tyson et al. Dec 2007 B2
7313430 Urquhart et al. Dec 2007 B2
7313440 Miesel Dec 2007 B2
7315759 Markowitz et al. Jan 2008 B2
7317947 Wahlstrand et al. Jan 2008 B2
7317948 King et al. Jan 2008 B1
7319899 Keizer Jan 2008 B2
7319904 Cross et al. Jan 2008 B2
7321798 Muhlenberg et al. Jan 2008 B2
7321837 Osorio et al. Jan 2008 B2
7322832 Kronich et al. Jan 2008 B2
7328057 Freas et al. Feb 2008 B2
7328068 Spinelli et al. Feb 2008 B2
7328069 Gerber Feb 2008 B2
7330760 Heruth et al. Feb 2008 B2
7337010 Howard et al. Feb 2008 B2
7343206 Sage et al. Mar 2008 B2
7346395 Lozano et al. Mar 2008 B2
7356369 Phillips et al. Apr 2008 B2
7359837 Drew Apr 2008 B2
7366572 Heruth et al. Apr 2008 B2
7367956 King May 2008 B2
7369891 Augustijn et al. May 2008 B2
7369893 Gunderson May 2008 B2
7369894 Gerber May 2008 B2
7385443 Denison Jun 2008 B1
7388378 Gray et al. Jun 2008 B2
7389147 Wahlstrand et al. Jun 2008 B2
7390311 Hildebrand et al. Jun 2008 B2
7391257 Denison et al. Jun 2008 B1
7392089 Wahlstrand et al. Jun 2008 B2
7395113 Heruth et al. Jul 2008 B2
7400927 Litvin Jul 2008 B1
7403820 DiLorenzo Jul 2008 B2
7406351 Wesselink Jul 2008 B2
7418292 Shafer Aug 2008 B2
7421297 Giftakis et al. Sep 2008 B2
7427280 Gerber Sep 2008 B2
7429938 Corndorf Sep 2008 B1
7433734 King Oct 2008 B2
7442183 Baudino et al. Oct 2008 B2
7447545 Heruth et al. Nov 2008 B2
7450996 MacDonald et al. Nov 2008 B2
7463917 Martinez Dec 2008 B2
7463928 Lee et al. Dec 2008 B2
7474247 Heinks et al. Jan 2009 B1
7479910 Heinks et al. Jan 2009 B1
7483748 Torgerson et al. Jan 2009 B2
7489966 Leinders et al. Feb 2009 B2
7489970 Lee et al. Feb 2009 B2
7491181 Heruth et al. Feb 2009 B2
7497844 Spear et al. Mar 2009 B2
7497863 Solar et al. Mar 2009 B2
7502217 Zhao et al. Mar 2009 B2
7505815 Lee et al. Mar 2009 B2
7505869 Hartlaub Mar 2009 B2
7515961 Germanson et al. Apr 2009 B2
7519431 Goetz et al. Apr 2009 B2
7519432 Bolea et al. Apr 2009 B2
7520890 Phillips Apr 2009 B2
7526339 Lahti et al. Apr 2009 B2
7526340 Drew Apr 2009 B2
7526341 Goetz et al. Apr 2009 B2
7529582 DiLorenzo May 2009 B1
7529586 Wahlstrand et al. May 2009 B2
7542803 Heruth et al. Jun 2009 B2
7546164 King Jun 2009 B2
7546166 Michels et al. Jun 2009 B2
7548775 Kipke et al. Jun 2009 B2
7548786 Lee et al. Jun 2009 B2
7551951 Osorio et al. Jun 2009 B1
7551960 Forsberg et al. Jun 2009 B2
7555345 Wahlstrand et al. Jun 2009 B2
7561921 Phillips et al. Jul 2009 B2
7563141 Alexander et al. Jul 2009 B2
7563541 Howard et al. Jul 2009 B2
7578819 Bleich et al. Aug 2009 B2
7580756 Schulte et al. Aug 2009 B2
7582387 Howard et al. Sep 2009 B2
7590451 Tronnes et al. Sep 2009 B2
7590453 Heruth et al. Sep 2009 B2
7590455 Heruth et al. Sep 2009 B2
7591970 Olson Sep 2009 B2
7594828 Alexander et al. Sep 2009 B2
7594889 St. Ores et al. Sep 2009 B2
7596399 Singhal et al. Sep 2009 B2
7596408 Singhal et al. Sep 2009 B2
7596415 Brabec et al. Sep 2009 B2
7599730 Hunter et al. Oct 2009 B2
7603161 Wurmfeld et al. Oct 2009 B2
7603177 Sieracki et al. Oct 2009 B2
7604629 Gerber et al. Oct 2009 B2
7604644 Schulte et al. Oct 2009 B2
7608458 Soykan et al. Oct 2009 B2
7610083 Drew et al. Oct 2009 B2
7611483 Gerber et al. Nov 2009 B2
7614743 Geiger Nov 2009 B2
7615015 Coleman Nov 2009 B2
7616998 Nuttin et al. Nov 2009 B2
7617002 Goetz Nov 2009 B2
7620454 Dinsmoor et al. Nov 2009 B2
7622303 Soykan et al. Nov 2009 B2
7622988 Denison et al. Nov 2009 B2
7623053 Terry et al. Nov 2009 B2
7623918 Goetz Nov 2009 B2
7623919 Goetz et al. Nov 2009 B2
7623923 Gerber et al. Nov 2009 B2
7623930 Zeijlemaker et al. Nov 2009 B2
7624293 Osorio et al. Nov 2009 B2
7628780 Bonner et al. Dec 2009 B2
7631415 Phillips et al. Dec 2009 B2
7632225 Stypulkowski Dec 2009 B2
7635541 Scott et al. Dec 2009 B2
7637867 Zdeblick Dec 2009 B2
7640059 Forsberg et al. Dec 2009 B2
7640060 Zdeblick Dec 2009 B2
7641992 Howard et al. Jan 2010 B2
7642013 Howard et al. Jan 2010 B2
7647111 Ries et al. Jan 2010 B2
7647116 Bauhahn Jan 2010 B2
7647117 Bauhahn Jan 2010 B2
7647121 Wahlstrand et al. Jan 2010 B2
7650291 Rosenfeld et al. Jan 2010 B2
7653433 Lozano et al. Jan 2010 B2
7657318 King et al. Feb 2010 B2
7657319 Goetz et al. Feb 2010 B2
7660620 Zeijlemaker et al. Feb 2010 B2
7660630 Dudding et al. Feb 2010 B2
7662140 Heruth et al. Feb 2010 B2
7662509 Howard et al. Feb 2010 B2
7663066 Tyson et al. Feb 2010 B2
7664551 Cigaina Feb 2010 B2
7664552 Wahlstrand et al. Feb 2010 B2
7668601 Hegland et al. Feb 2010 B2
7671594 Gray Mar 2010 B2
7676271 Wahlstrand et al. Mar 2010 B2
7676273 Goetz et al. Mar 2010 B2
7676274 Hung et al. Mar 2010 B2
7680540 Jensen et al. Mar 2010 B2
7682355 Gerber et al. Mar 2010 B2
7682745 Howard et al. Mar 2010 B2
7684860 Wahlstrand et al. Mar 2010 B2
7684866 Fowler et al. Mar 2010 B2
7684873 Gerber Mar 2010 B2
7689289 King Mar 2010 B2
7697972 Verard et al. Apr 2010 B2
7697995 Cross et al. Apr 2010 B2
7706124 Zhao et al. Apr 2010 B2
7706889 Gerber et al. Apr 2010 B2
7711421 Shafer et al. May 2010 B2
7711428 Janzig et al. May 2010 B2
7711436 Stone May 2010 B2
7713194 Zdeblick May 2010 B2
7713195 Zdeblick May 2010 B2
7720548 King May 2010 B2
7729768 White et al. Jun 2010 B2
7729780 Vardiman Jun 2010 B2
7738958 Zdeblick et al. Jun 2010 B2
7742823 King et al. Jun 2010 B2
7756588 Jog et al. Jul 2010 B2
7765012 Gerber Jul 2010 B2
7769472 Gerber Aug 2010 B2
7797029 Gibson et al. Sep 2010 B2
7822482 Gerber Oct 2010 B2
7822483 Stone et al. Oct 2010 B2
7853303 Nikumb et al. Dec 2010 B2
7877149 Zdeblick Jan 2011 B2
7899539 Whitehurst et al. Mar 2011 B2
7925329 Zdeblick et al. Apr 2011 B2
7930035 Dilorenzo Apr 2011 B2
7935056 Zdeblick May 2011 B2
7941202 Hetke et al. May 2011 B2
7945329 Bedenbaugh May 2011 B2
7945336 Sauter-Starace et al. May 2011 B2
7969161 Behzadi et al. Jun 2011 B2
7974705 Zdeblick et al. Jul 2011 B2
7978064 Zdeblick et al. Jul 2011 B2
7979105 Kipke et al. Jul 2011 B2
7983751 Zdeblick et al. Jul 2011 B2
7991481 Benabid et al. Aug 2011 B2
8000794 Lozano Aug 2011 B2
8000808 Hegland et al. Aug 2011 B2
8010202 Shah et al. Aug 2011 B2
8024022 Schulman et al. Sep 2011 B2
8032224 Miesel et al. Oct 2011 B2
8036737 Goetz et al. Oct 2011 B2
8036743 Savage et al. Oct 2011 B2
8036748 Zdeblick et al. Oct 2011 B2
8055334 Savage et al. Nov 2011 B2
8055353 Kreidler et al. Nov 2011 B2
8090450 Swoyer et al. Jan 2012 B2
8099170 Jensen et al. Jan 2012 B2
8108049 King Jan 2012 B2
8114021 Robertson et al. Feb 2012 B2
8115618 Robertson et al. Feb 2012 B2
8121687 Jensen et al. Feb 2012 B2
8121702 King Feb 2012 B2
8123684 Zdeblick Feb 2012 B2
8170676 Greenberg et al. May 2012 B2
8171621 Swanson et al. May 2012 B2
8172762 Robertson May 2012 B2
8187161 Li et al. May 2012 B2
8195308 Frank et al. Jun 2012 B2
8204586 Zdeblick Jun 2012 B2
8224417 Vetter Jul 2012 B2
8224462 Westlund et al. Jul 2012 B2
8244377 Pianca et al. Aug 2012 B1
8258962 Robertson et al. Sep 2012 B2
8261428 Fang et al. Sep 2012 B2
8271094 Moffitt et al. Sep 2012 B1
8280514 Lozano et al. Oct 2012 B2
8295943 Eggen et al. Oct 2012 B2
8315686 Llinas et al. Nov 2012 B2
8321025 Bedenbaugh Nov 2012 B2
8332020 Zdeblick Dec 2012 B2
8332046 Anderson et al. Dec 2012 B2
8355768 Masmanidis et al. Jan 2013 B2
8374703 Imran Feb 2013 B2
8412347 Zdeblick Apr 2013 B2
8463353 Seymour Jun 2013 B2
8463398 Jackson et al. Jun 2013 B2
8467877 Imran Jun 2013 B2
8473061 Moffitt et al. Jun 2013 B2
8473069 Bi et al. Jun 2013 B2
8489203 Ortmann Jul 2013 B2
8509872 Lee et al. Aug 2013 B2
8509876 Karmarkar Aug 2013 B2
8509920 Wahlstrand et al. Aug 2013 B2
8560085 Moffitt et al. Oct 2013 B2
8565894 Vetter et al. Oct 2013 B2
8571665 Moffitt et al. Oct 2013 B2
8583253 Shi et al. Nov 2013 B1
8620452 King et al. Dec 2013 B2
8626312 King et al. Jan 2014 B2
8634934 Kokones et al. Jan 2014 B2
8644903 Osa et al. Feb 2014 B1
8649879 Digiore et al. Feb 2014 B2
8666509 Howard et al. Mar 2014 B2
8694105 Martens et al. Apr 2014 B2
8694123 Wahlstrand et al. Apr 2014 B2
8694127 Pianca et al. Apr 2014 B2
8731673 Vetter et al. May 2014 B2
8738154 Zdeblick et al. May 2014 B2
8744596 Howard Jun 2014 B2
8755906 Moffitt et al. Jun 2014 B2
8762065 Dilorenzo Jun 2014 B2
8774891 Osa et al. Jul 2014 B1
8788056 King et al. Jul 2014 B2
8788063 Chen Jul 2014 B2
8788064 Mercanzini et al. Jul 2014 B2
8792993 Pianca et al. Jul 2014 B2
8800140 Hetke et al. Aug 2014 B2
8825175 King Sep 2014 B2
8831739 McCreery et al. Sep 2014 B2
8831742 Pianca et al. Sep 2014 B2
8849369 Cogan et al. Sep 2014 B2
8849415 Bedenbaugh Sep 2014 B2
8862242 Pianca Oct 2014 B2
8874232 Chen Oct 2014 B2
8875391 Pianca et al. Nov 2014 B2
8897891 Romero Nov 2014 B2
8923982 Howard Dec 2014 B2
8934965 Rogers et al. Jan 2015 B2
8934980 Pless et al. Jan 2015 B2
8938300 Rosero Jan 2015 B2
8938308 Meadows Jan 2015 B2
8958862 Hetke et al. Feb 2015 B2
8968331 Sochor Mar 2015 B1
8977335 Putz Mar 2015 B2
8977367 Elahi et al. Mar 2015 B2
8989864 Funderburk et al. Mar 2015 B2
9008747 Seymour et al. Apr 2015 B2
9014796 Kipke et al. Apr 2015 B2
9044590 Greenberg et al. Jun 2015 B2
9061134 Askin et al. Jun 2015 B2
9079013 Digiore et al. Jul 2015 B2
9089689 Govea Jul 2015 B2
9089690 Greenberg et al. Jul 2015 B2
9095267 Halpern et al. Aug 2015 B2
9149630 Howard et al. Oct 2015 B2
9211401 Frewin et al. Dec 2015 B2
9211402 Moffitt et al. Dec 2015 B2
9220897 Perryman et al. Dec 2015 B2
9227050 Romero Jan 2016 B2
9248272 Romero Feb 2016 B2
9248275 Digiore et al. Feb 2016 B2
9265465 Najafi et al. Feb 2016 B2
9265928 Pellinen et al. Feb 2016 B2
9283375 Moffitt et al. Mar 2016 B2
9289151 Kipke et al. Mar 2016 B2
9289596 Leven Mar 2016 B2
9295830 Pianca Mar 2016 B2
9314614 Bedenbaugh Apr 2016 B2
9358398 Moffitt et al. Jun 2016 B2
9364659 Rao Jun 2016 B1
9381347 Howard et al. Jul 2016 B2
9381348 Romero et al. Jul 2016 B2
9381356 Parker et al. Jul 2016 B2
9399128 Tooker et al. Jul 2016 B2
9427567 Romero Aug 2016 B2
9474895 Digiore et al. Oct 2016 B2
9498620 Romero et al. Nov 2016 B2
9517020 Shacham-Diamand et al. Dec 2016 B2
9592377 Greenberg et al. Mar 2017 B2
9604051 Vetter et al. Mar 2017 B2
9662494 Young May 2017 B2
9700715 Dou Jul 2017 B2
9743878 Drew Aug 2017 B2
9775983 Digiore et al. Oct 2017 B2
9775988 Govea et al. Oct 2017 B2
9827413 Barker et al. Nov 2017 B2
9833611 Govea et al. Dec 2017 B2
9855428 Henry et al. Jan 2018 B2
9861288 Ma et al. Jan 2018 B2
9925368 Ryu et al. Mar 2018 B2
10046165 Frewin et al. Aug 2018 B2
20010051802 Woloszko Dec 2001 A1
20010051819 Fischell et al. Dec 2001 A1
20020062143 Baudino et al. May 2002 A1
20020116042 Boling Aug 2002 A1
20030004553 Grill et al. Jan 2003 A1
20030023282 Barrett et al. Jan 2003 A1
20030036780 Barrett et al. Feb 2003 A1
20030060822 Schaer et al. Mar 2003 A1
20030083724 Jog et al. May 2003 A1
20030100823 Kipke et al. May 2003 A1
20030135253 Kokones et al. Jul 2003 A1
20030176892 Shalev Sep 2003 A1
20040002635 Hargrove et al. Jan 2004 A1
20040015205 Whitehurst et al. Jan 2004 A1
20040039434 Schrom et al. Feb 2004 A1
20040102828 Lowry et al. May 2004 A1
20040122335 Sackellares et al. Jun 2004 A1
20040133390 Osorio et al. Jul 2004 A1
20040138517 Osorio et al. Jul 2004 A1
20040138536 Frei et al. Jul 2004 A1
20040138720 Naisberg et al. Jul 2004 A1
20040138722 Carroll et al. Jul 2004 A1
20040152958 Frei et al. Aug 2004 A1
20040172089 Whitehurst et al. Sep 2004 A1
20040193021 Zdeblick et al. Sep 2004 A1
20040215288 Lee et al. Oct 2004 A1
20040220637 Zdeblick et al. Nov 2004 A1
20040225335 Whitehurst et al. Nov 2004 A1
20040243011 Plaza Dec 2004 A1
20040249417 Ransbury et al. Dec 2004 A1
20040254483 Zdeblick et al. Dec 2004 A1
20050004627 Gibson et al. Jan 2005 A1
20050008660 Kipke et al. Jan 2005 A1
20050010261 Luders et al. Jan 2005 A1
20050021103 DiLorenzo Jan 2005 A1
20050027284 Lozano et al. Feb 2005 A1
20050033136 Govari et al. Feb 2005 A1
20050038489 Grill Feb 2005 A1
20050049655 Boveja et al. Mar 2005 A1
20050070971 Fowler et al. Mar 2005 A1
20050075681 Rezai et al. Apr 2005 A1
20050113882 Cameron et al. May 2005 A1
20050137647 Wallace et al. Jun 2005 A1
20050143790 Kipke et al. Jun 2005 A1
20050154425 Boveja et al. Jul 2005 A1
20050171522 Christopherson Aug 2005 A1
20050171558 Abovitz et al. Aug 2005 A1
20050182455 Thrope et al. Aug 2005 A1
20050209511 Heruth et al. Sep 2005 A1
20050209513 Heruth et al. Sep 2005 A1
20050209643 Heruth et al. Sep 2005 A1
20050222642 Przybyszewski et al. Oct 2005 A1
20050240242 DiLorenzo Oct 2005 A1
20050245988 Miesel Nov 2005 A1
20060004422 De Ridder Jan 2006 A1
20060030897 Gilmer et al. Feb 2006 A1
20060041295 Osypka Feb 2006 A1
20060049957 Surgenor et al. Mar 2006 A1
20060058588 Zdeblick Mar 2006 A1
20060058727 Bernabei Mar 2006 A1
20060058855 Gill Mar 2006 A1
20060084965 Young Apr 2006 A1
20060095029 Young May 2006 A1
20060095105 Jog et al. May 2006 A1
20060116581 Zdeblick et al. Jun 2006 A1
20060129203 Garabedian et al. Jun 2006 A1
20060135877 Giftakis et al. Jun 2006 A1
20060149336 Meadows Jul 2006 A1
20060149337 John Jul 2006 A1
20060167497 Armstrong et al. Jul 2006 A1
20060173263 He et al. Aug 2006 A1
20060173510 Besio et al. Aug 2006 A1
20060178709 Foster et al. Aug 2006 A1
20060184060 Belalcazar et al. Aug 2006 A1
20060195154 Jaax et al. Aug 2006 A1
20060200206 Firlik et al. Sep 2006 A1
20060212090 Lozano et al. Sep 2006 A1
20060241717 Whitehurst et al. Oct 2006 A1
20060258951 Bleich et al. Nov 2006 A1
20060264777 Drew Nov 2006 A1
20060276866 McCreery Dec 2006 A1
20060282014 Kipke et al. Dec 2006 A1
20060293720 DiLorenzo Dec 2006 A1
20060293721 Tarver et al. Dec 2006 A1
20070027498 Maschino et al. Feb 2007 A1
20070027500 Maschino et al. Feb 2007 A1
20070027514 Gerber Feb 2007 A1
20070043268 Russell Feb 2007 A1
20070060974 Lozano Mar 2007 A1
20070067002 Lozano Mar 2007 A1
20070067003 Sanchez et al. Mar 2007 A1
20070088403 Wyler et al. Apr 2007 A1
20070088404 Wyler et al. Apr 2007 A1
20070093870 Maschino Apr 2007 A1
20070100389 Jaax et al. May 2007 A1
20070100392 Maschino et al. May 2007 A1
20070100393 Whitehurst et al. May 2007 A1
20070100398 Sloan May 2007 A1
20070106143 Flaherty May 2007 A1
20070123765 Hetke et al. May 2007 A1
20070123944 Zdeblick May 2007 A1
20070135721 Zdeblick Jun 2007 A1
20070142872 Mickle et al. Jun 2007 A1
20070150024 Leyde et al. Jun 2007 A1
20070173890 Armstrong Jul 2007 A1
20070173896 Zdeblick Jul 2007 A1
20070173897 Zdeblick Jul 2007 A1
20070173901 Reeve Jul 2007 A1
20070173908 Begnaud Jul 2007 A1
20070179558 Gliner et al. Aug 2007 A1
20070179569 Zdeblick Aug 2007 A1
20070185537 Zdeblick Aug 2007 A1
20070185544 Dawant et al. Aug 2007 A1
20070185548 Zdeblick Aug 2007 A1
20070185549 Zdeblick Aug 2007 A1
20070197892 Shen et al. Aug 2007 A1
20070203537 Goetz et al. Aug 2007 A1
20070203546 Stone et al. Aug 2007 A1
20070208394 King et al. Sep 2007 A1
20070213784 Pless Sep 2007 A1
20070213785 Osorio et al. Sep 2007 A1
20070213786 Sackellares et al. Sep 2007 A1
20070219591 Zdeblick et al. Sep 2007 A1
20070225674 Molnar et al. Sep 2007 A1
20070225773 Shen et al. Sep 2007 A1
20070225774 Eskandar et al. Sep 2007 A1
20070233192 Craig Oct 2007 A1
20070249953 Frei et al. Oct 2007 A1
20070249954 Virag et al. Oct 2007 A1
20070250133 Carlson et al. Oct 2007 A1
20070255323 Werder et al. Nov 2007 A1
20070255338 Wahlstrand Nov 2007 A1
20070255374 Kolafa et al. Nov 2007 A1
20070255531 Drew Nov 2007 A1
20070265683 Ehrlich Nov 2007 A1
20070282389 Moxon et al. Dec 2007 A1
20070293908 Cowan et al. Dec 2007 A1
20080021514 Pless Jan 2008 A1
20080021517 Dietrich Jan 2008 A1
20080027289 Zdeblick Jan 2008 A1
20080027487 Patel et al. Jan 2008 A1
20080027503 Marrosu et al. Jan 2008 A1
20080027504 Bedenbaugh Jan 2008 A1
20080027514 Demulling et al. Jan 2008 A1
20080027540 Cumming Jan 2008 A1
20080039895 Fowler et al. Feb 2008 A1
20080046012 Covalin et al. Feb 2008 A1
20080046013 Lozano Feb 2008 A1
20080058630 Robertson Mar 2008 A1
20080077186 Thompson et al. Mar 2008 A1
20080077191 Morrell Mar 2008 A1
20080103547 Okun et al. May 2008 A1
20080103548 Fowler et al. May 2008 A1
20080103578 Gerber May 2008 A1
20080114417 Leyde May 2008 A1
20080119900 DiLorenzo May 2008 A1
20080139870 Gliner et al. Jun 2008 A1
20080140152 Imran et al. Jun 2008 A1
20080154328 Thompson et al. Jun 2008 A1
20080154331 John et al. Jun 2008 A1
20080154340 Goetz et al. Jun 2008 A1
20080161881 Firlik et al. Jul 2008 A1
20080161896 Sauter-Starace Jul 2008 A1
20080172103 Kao et al. Jul 2008 A1
20080177196 Burdick et al. Jul 2008 A1
20080188905 Swartz Aug 2008 A1
20080195166 Sun et al. Aug 2008 A1
20080195227 Boling et al. Aug 2008 A1
20080208283 Vetter et al. Aug 2008 A1
20080208287 Palermo et al. Aug 2008 A1
20080215125 Farah et al. Sep 2008 A1
20080221642 Humayun et al. Sep 2008 A1
20080242976 Robertson et al. Oct 2008 A1
20080255439 Tang et al. Oct 2008 A1
20080255629 Jenson et al. Oct 2008 A1
20080255647 Jensen et al. Oct 2008 A1
20080269835 Carlson et al. Oct 2008 A1
20080269842 Giftakis et al. Oct 2008 A1
20080275526 Lozano Nov 2008 A1
20080284599 Zdeblick et al. Nov 2008 A1
20080294218 Savage et al. Nov 2008 A1
20080300652 Lim et al. Dec 2008 A1
20080306394 Zdeblick et al. Dec 2008 A1
20080312726 Frank et al. Dec 2008 A1
20080316020 Robertson et al. Dec 2008 A1
20090027504 Lim et al. Jan 2009 A1
20090062879 Li et al. Mar 2009 A1
20090082645 Hafezi et al. Mar 2009 A1
20090105784 Massoud-Ansari et al. Apr 2009 A1
20090118806 Vetter et al. May 2009 A1
20090132042 Hetke et al. May 2009 A1
20090171416 Firlik et al. Jul 2009 A1
20090177144 Masmanidis et al. Jul 2009 A1
20090187196 Vetter Jul 2009 A1
20090204183 Kreidler et al. Aug 2009 A1
20090240314 Kong et al. Sep 2009 A1
20090253977 Kipke et al. Oct 2009 A1
20090256702 Robertson et al. Oct 2009 A1
20090292325 Cederna et al. Nov 2009 A1
20090299174 Wright et al. Dec 2009 A1
20090306728 Wright et al. Dec 2009 A1
20090306729 Doerr Dec 2009 A1
20090312770 Kozai et al. Dec 2009 A1
20090318824 Nishida et al. Dec 2009 A1
20090325424 Aarts et al. Dec 2009 A1
20100014541 Harriman Jan 2010 A1
20100015274 Fill Jan 2010 A1
20100030298 Martens et al. Feb 2010 A1
20100036468 Decre et al. Feb 2010 A1
20100047376 Imbeau et al. Feb 2010 A1
20100069717 Hafezi et al. Mar 2010 A1
20100076536 Merz et al. Mar 2010 A1
20100087853 Kipke et al. Apr 2010 A1
20100100152 Martens et al. Apr 2010 A1
20100106178 Obermiller et al. Apr 2010 A1
20100114193 Lozano et al. May 2010 A1
20100114234 Zdeblick May 2010 A1
20100114250 Zdeblick May 2010 A1
20100130844 Williams et al. May 2010 A1
20100145216 He et al. Jun 2010 A1
20100145414 Decre et al. Jun 2010 A1
20100152747 Padiy et al. Jun 2010 A1
20100198315 Martens et al. Aug 2010 A1
20100249883 Zdeblick Sep 2010 A1
20100274305 Gliner et al. Oct 2010 A1
20100292602 Worrell et al. Nov 2010 A1
20100298908 Vardiman Nov 2010 A1
20100298917 Vardiman Nov 2010 A1
20100298918 Vardiman Nov 2010 A1
20100312188 Robertson et al. Dec 2010 A1
20100312228 Zdeblick et al. Dec 2010 A1
20100318163 Zdeblick Dec 2010 A1
20100331807 Whitehurst et al. Dec 2010 A1
20110001488 Behzadi et al. Jan 2011 A1
20110022124 Zdeblick et al. Jan 2011 A1
20110034964 Bi et al. Feb 2011 A1
20110034970 Barker Feb 2011 A1
20110040203 Savage et al. Feb 2011 A1
20110071766 Dolan et al. Mar 2011 A1
20110130809 Zdeblick Jun 2011 A1
20110152988 Whitehurst et al. Jun 2011 A1
20110154655 Hetke et al. Jun 2011 A1
20110184495 Wang et al. Jul 2011 A1
20110190860 Harberts et al. Aug 2011 A1
20110196454 Strand et al. Aug 2011 A1
20110208225 Martens et al. Aug 2011 A1
20110213382 Decre et al. Sep 2011 A1
20110218417 Boogaard et al. Sep 2011 A1
20110224757 Zdeblick et al. Sep 2011 A1
20110224765 Harberts et al. Sep 2011 A1
20110224766 Tol et al. Sep 2011 A1
20110282179 Zdeblick Nov 2011 A1
20120004520 Whitworth et al. Jan 2012 A1
20120004527 Thompson et al. Jan 2012 A1
20120004716 Langhammer et al. Jan 2012 A1
20120007734 Berkman et al. Jan 2012 A1
20120022341 Zdeblick Jan 2012 A1
20120035684 Thompson et al. Feb 2012 A1
20120053344 Lagos Gonzalez Mar 2012 A1
20120059444 Pardoel et al. Mar 2012 A1
20120062379 Hafezi et al. Mar 2012 A1
20120095355 Zdeblick Apr 2012 A1
20120109262 Martens May 2012 A1
20120109599 Martens May 2012 A1
20120116188 Frank et al. May 2012 A1
20120136420 Pardoel et al. May 2012 A1
20120150256 Martens Jun 2012 A1
20120184837 Martens et al. Jul 2012 A1
20120253442 Gliner et al. Oct 2012 A1
20120277821 Martens et al. Nov 2012 A1
20120296444 Greenberg et al. Nov 2012 A1
20120302912 Moffitt et al. Nov 2012 A1
20120303088 Van Kaam et al. Nov 2012 A1
20120303089 Martens et al. Nov 2012 A1
20120303107 Decre et al. Nov 2012 A1
20120316630 Firlik et al. Dec 2012 A1
20130009691 Blanken et al. Jan 2013 A1
20130030366 Robertson et al. Jan 2013 A1
20130046356 Jensen et al. Feb 2013 A1
20130060102 Zdeblick Mar 2013 A1
20130085361 Mercanzini Apr 2013 A1
20130131754 Sarvazyan May 2013 A1
20130144132 Hafezi et al. Jun 2013 A1
20130172716 Lozano et al. Jul 2013 A1
20130193950 Hafezi et al. Aug 2013 A1
20130204318 Young Aug 2013 A1
20130223028 Arne et al. Aug 2013 A1
20130231188 Berberich et al. Sep 2013 A1
20130282090 Decre et al. Oct 2013 A1
20130345780 Tabada et al. Dec 2013 A1
20130345789 Havel et al. Dec 2013 A1
20140039578 Whitehurst et al. Feb 2014 A1
20140066999 Carcieri et al. Mar 2014 A1
20140200633 Moffitt Jul 2014 A1
20140277284 Chen et al. Sep 2014 A1
20150051678 Reed et al. Feb 2015 A1
20150105774 Lindquist et al. Apr 2015 A1
20150142090 Duijsens et al. May 2015 A1
20150151111 Pianca et al. Jun 2015 A1
20150209578 Kast et al. Jul 2015 A1
20150246233 Kaemmerer Sep 2015 A1
20150290452 Kokones et al. Oct 2015 A1
20150335258 Masmanidis Nov 2015 A1
20150355413 Bhagavatula Dec 2015 A1
20150360023 Howard et al. Dec 2015 A1
20160008592 Romero et al. Jan 2016 A1
20160023003 Perryman et al. Jan 2016 A1
20160074651 Moffitt et al. Mar 2016 A1
20160144186 Kaemmerer et al. May 2016 A1
20160228706 Hershey et al. Aug 2016 A1
20160331953 Reed et al. Nov 2016 A1
20160331975 Henry et al. Nov 2016 A1
20160361535 Perryman et al. Dec 2016 A1
20170007813 Negi et al. Jan 2017 A1
20170049345 Single Feb 2017 A1
20170136238 Hartig et al. May 2017 A1
20170143982 Mercanzini May 2017 A1
20170189700 Moffitt et al. Jul 2017 A1
20170197086 Howard et al. Jul 2017 A1
20170266432 Seeley et al. Sep 2017 A1
20170296808 Greenberg et al. Oct 2017 A1
20170361101 Single Dec 2017 A1
20180185656 Shepard et al. Jul 2018 A1
Foreign Referenced Citations (96)
Number Date Country
101027085 Aug 2007 CN
101600470 Dec 2009 CN
201871104 Jun 2011 CN
102274074 Dec 2011 CN
102341036 Feb 2012 CN
0 586 664 Mar 1994 EP
0 677 743 Oct 1995 EP
0 743 839 Nov 1996 EP
0 892 654 Jan 1999 EP
0 895 483 Feb 1999 EP
0 959 942 Dec 1999 EP
1 048 319 Nov 2000 EP
1 062 973 Dec 2000 EP
1 102 607 May 2001 EP
1 257 320 Nov 2002 EP
1 446 189 Aug 2004 EP
1 514 576 Mar 2005 EP
1 750 798 Feb 2007 EP
1 890 764 Feb 2008 EP
1 931 419 Jun 2008 EP
1 985 579 Oct 2008 EP
1 993 665 Nov 2008 EP
2 046 441 Apr 2009 EP
2 066 396 Jun 2009 EP
2 069 003 Jun 2009 EP
2 131 916 Dec 2009 EP
2 144 665 Jan 2010 EP
2 167 188 Mar 2010 EP
2 320 221 May 2011 EP
2 341 979 Jul 2011 EP
2 389 975 Nov 2011 EP
2 456 513 May 2012 EP
2 476 453 Jul 2012 EP
2 542 303 Jan 2013 EP
2 559 454 Feb 2013 EP
2 604 313 Jun 2013 EP
2 618 889 Jul 2013 EP
2 620 179 Jul 2013 EP
2 623 154 Aug 2013 EP
2 626 108 Aug 2013 EP
2 626 109 Aug 2013 EP
2 626 110 Aug 2013 EP
2 626 111 Aug 2013 EP
2 656 875 Oct 2013 EP
2 656 876 Oct 2013 EP
2 664 354 Nov 2013 EP
2 674 193 Dec 2013 EP
2 862 595 Apr 2015 EP
3 111 835 Jan 2017 EP
3 231 476 Oct 2017 EP
2005-052647 Mar 2005 JP
2012-179333 Sep 2012 JP
WO-9810010 Mar 1998 WO
WO-03022354 Mar 2003 WO
WO-03028521 Apr 2003 WO
WO-03066152 Aug 2003 WO
WO-03066153 Aug 2003 WO
WO-03066157 Aug 2003 WO
WO-2004043536 May 2004 WO
WO-2018068013 May 2004 WO
WO-2004045707 Jun 2004 WO
WO-2005002467 Jan 2005 WO
WO-2005067792 Jul 2005 WO
WO-2005112216 Nov 2005 WO
WO-2006104432 Oct 2006 WO
WO-2007002144 Jan 2007 WO
WO-2007009070 Jan 2007 WO
WO-2007011611 Jan 2007 WO
WO-2007025356 Mar 2007 WO
WO-2007028003 Mar 2007 WO
WO-2007042999 Apr 2007 WO
WO-2007092330 Aug 2007 WO
WO-2007100428 Sep 2007 WO
WO-2007108718 Sep 2007 WO
WO-2008003318 Jan 2008 WO
WO-2008005478 Jan 2008 WO
WO-2008016881 Feb 2008 WO
WO-2008035285 Mar 2008 WO
WO-2008035344 Mar 2008 WO
WO-2008051463 May 2008 WO
WO-2008064269 May 2008 WO
WO-2008068759 Jun 2008 WO
WO-2008075294 Jun 2008 WO
WO-2008077440 Jul 2008 WO
WO-2008088897 Jul 2008 WO
WO-2008089726 Jul 2008 WO
WO-2008107822 Sep 2008 WO
WO-2008109298 Sep 2008 WO
WO-2008133616 Nov 2008 WO
WO-2008133683 Nov 2008 WO
WO-2008138305 Nov 2008 WO
WO-2010014686 Feb 2010 WO
WO-2010055421 May 2010 WO
WO-2011000791 Jan 2011 WO
WO-2011115999 Sep 2011 WO
WO-2013014206 Jan 2013 WO
Non-Patent Literature Citations (133)
Entry
US 8,388,533 B2, 03/2013, Hafezi et al. (withdrawn)
US 8,469,885 B2, 06/2013, Hafezi et al. (withdrawn)
Extended European Search Report for EP Application No. 18208814.6 dated Mar. 28, 2019.
Final Office Action on U.S. Appl. No. 15/369,766 dated Feb. 7, 2019
International Preliminary Report on Patentability and Written Opinion for PCT/IB2017/050551 dated Aug. 16, 2018.
Notice of Allowance on U.S. Appl. No. 14/731,296 dated Aug. 15, 2018.
Notice of Allowance on U.S. Appl. No. 15/185,709 dated Nov. 9, 2018.
Notice of Allowance on U.S. Appl. No. 15/281,468 dated Jun. 1, 2018.
Notice of Allowance on U.S. Appl. No. 15/878,066 dated Oct. 3, 2018.
Notice of Allowance on U.S. Appl. No. 15/878,066 dated Dec. 5, 2018.
Office Action for CA Application No. 2,795,159 dated Dec. 18, 2018.
Office Action for Chinese Application No. 201580016170.1 dated Jan. 28, 2019.
Notice of Allowance for U.S. Appl. No. 15/369,766 dated Oct. 17, 2019 (12 pages).
Bucher et al., “Low-impedance thin-film polycrystalline silicon microelectrodes for extracellular stimulation and recording”, Biosensors & Bioelectronics, vol. 14, 1999, pp. 639-649 (11 pages).
European Search Report on EP 16190439 dated Jul. 19, 2017 (2 pages).
Extended European Search Report on EP 19165102.5 dated Jul. 8, 2019 (7 pages).
Final Office Action on U.S. Appl. No. 16/015,625 dated Dec. 28, 2018 (13 pages).
Hosp et al., “Thin-film epidural microelectrode arrays for somatosensory and motor cortex mapping in rat”, Journal of Neuroscience Methods, vol. 172, 2008, pp. 255-262 (8 pages).
International Search Report and Written Opinion of the International Searching Authority on PCT/IB2019/051635 dated Jun. 3, 2019 (13 pages).
International Search Report and Written Opinion of the International Searching Authority on PCT/IB2019/053275 dated Jul. 4, 2019 (12 pages).
Janders et al., “Novel Thin Film Titanium Nitride Micro-Electrodes With Excellent Charge Transfer Capability for Cell Stimulation and Sensing Applications”, 18th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 1996, Amsterdam (3 pages).
Moxon et al., “Nanostructured Surface Modification of Ceramic-Based Microelectrodes to Enhance Biocompatibility for a Direct Brain-Machine Interface”, IEEE Transactions on Biomedical Engineering, vol. 51, No. 6, Jun. 2004, pp. 881-889 (9 pages).
Non-Final Office Action on U.S. Appl. No. 15/369,766 dated May 31, 2019 (10 pages).
Non-Final Office Action on U.S. Appl. No. 16/015,625 dated Aug. 9, 2018 (14 pages).
Notice of Allowance on U.S. Appl. No. 15/185,709 dated Jun. 10, 2019 (2 pages).
Notice of Allowance on U.S. Appl. No. 15/185,709 dated Apr. 26, 2019 (5 pages).
Notice of Allowance on U.S. Appl. No. 15/281,468 dated Jul. 27, 2018 (2 pages).
Notice of Allowance on U.S. Appl. No. 16/015,625 dated Mar. 28, 2019 (8 pages).
Notice of Allowance on U.S. Appl. No. 16/015,625 dated May 8, 2019 (8 pages).
Notice of Reasons for Rejection on JP 2017-530450 dated Jul. 11, 2019 (4 pages).
Office Action on CN 201580016170.1 dated Jan. 28, 2019 (10 pages).
Ziaie et al., “A Single-Channel Implantable Microstimulator for Functional Neuromuscular Stimulation”, IEEE Transactions on Biomedical Engineering, vol. 44, No. 10, Oct. 1997, pp. 909-920 (12 pages).
Cogan, S., et al. “Plasma-enhanced chemical vapor deposited silicon carbide as an implantable dielectric coating.” Journal of Biomedical Materials Research Part A 67.3 (2003): 856-867.
Communication from the European Patent Office in Application No. 09795810.2 dated Sep. 14, 2011.
EIC Biomedical, “Thin-film Encapsulation for Neural Recording and Stimulation Electrodes”, Silicon carbide and oxycarbide, Apr. 2008: pp. 1-2.
European Search Report for Appl. Serial No. 09803534.8 dated Jul. 21, 2011.
Fierce Medical Devices, “Medtronic Announces First U.S. Implant of World's Smallest, Minimally Invasive Cardiac Pacemaker”, Feb. 20, 2014, pp. 1-3.
Gibney, “St. Jude places its Nanostim leadless pacemaker in a U.K. patient”, Fierce Medical Devices, Jan. 27, 2014, pp. 1-3.
International Search Report and Written Opinion in PCT/US09/52077 dated Sep. 25, 2009.
International Search Report for PCT/IB2009/007715 dated Apr. 22, 2010.
Written Opinion of the International Search Authority for PCT/IB2009/07715 dated May 12, 2011.
Extended European Search Report for EP 19174013.3 dated Oct. 8, 2019 (7 pages).
U.S. Appl. No. 07/151,961, filed Feb. 3, 1988, Masahiko Okunuki et al.
U.S. Appl. No. 07/184,829, filed Apr. 22, 1988, Tsutsui et al.
Australian Patent Examination Report No. 1 dated Jan. 30, 2014 in corresponding Australian Application No. 2010326613, 2 pages.
Australian Patent Examination Report No. 1 dated Jan. 31, 2014 in corresponding Australian Application No. 2009315316, 3 pages.
Benabid, et al. “Combined (Thalamotomy and Stimulation) Stereotactic Surgery of the VIM Thalamic Nucleus for Bilateral Parkinson Disease”, Proceedings of the Meeting of the American Society for Stereotactic and Functional Neurosurgery, Montreal 1987 Appl. Neurophysiol. 50: 344-346.
Canadian Office Action for Application No. 2,743,575 dated Sep. 25, 2014, 3 pages.
Decision of Rejection and Decision for Dismissal of Amendment in JP Patent Application No. 2011-543841 dated May 15, 2014.
Decision of Rejection for Japanese Appl. Ser. No. 2012-541491 dated Oct. 26, 2015.
English translation of Notice of Reasons for Rejection in JP application No. 2011-543841 dated Oct. 21, 2013.
European Communication and Search Report for Application No. 09795810.2 dated Sep. 25, 2013.
European Communication dated May 22, 2013 including search report for EP application No. 12198290.4-1652.
European Search Report for Appl. Ser. No. 09803534.8 dated Jul. 21, 2011.
European Search Report for Appl. Ser. No. 13169272.5 dated Aug. 30, 2013.
European Search Report for application No. EP 14172592 dated Aug. 28, 2014, 8 pages.
Examination Report for EP09795810.2 dated Jun. 22, 2012.
Examination Report from European Patent Office in 09 795 810.2 dated May 8, 2014.
Examination Report in AU Patent Application No. 2009276603 dated Mar. 3, 2014.
Examination report in AU Patent Application No. 2011234422 dated Feb. 11, 2014.
Examination Report in EP Patent Application No. 11 711 884.4 dated Mar. 28, 2014.
International Preliminary Report on Patentability for PCT/EP2010/068658 dated Jun. 5, 2012.
International Preliminary Report on Patentability for PCT/IB2009/007715 dated May 17, 2011.
International Preliminary Report on Patentability for PCT/US2009/052077 dated Feb. 1, 2011.
International Search Report and Written Opinion for PCT Appl. Ser. No. PCT/IB2015/053610 dated Jul. 20, 2015.
International Search Report and Written Opinion for PCT Appl. Ser. No. PCT/IB2015/056437 dated Nov. 5, 2015.
International Search Report and Written Opinion for PCT Appl. Ser. No. PCT/IB2015/056438 dated Nov. 5, 2015.
International Search Report and Written Opinion for PCT/EP2010/068658 dated Mar. 21, 2011.
International Search Report and Written Opinion in Application No. PCT/EP2011/055045 dated Jul. 18, 2011.
Notice of Allowance for U.S. Appl. No. 14/287,917 dated Apr. 15, 2015.
Notice of Allowance on U.S. Appl. No. 14/470,423 dated Jun. 15, 2016.
Notice of Allowance on U.S. Appl. No. 15/194,033 dated Oct. 27, 2016.
Notice of Reasons for Rejection for Japanese Patent Application No. 2011-543841 dated May 30, 2013.
Notice of Reasons for Rejection in JP Patent Application No. 2011-521276 dated Mar. 3, 2014.
Notice of Reasons for Rejection in JP Patent Application No. 2011-521276 dated May 30, 2013.
Notice of Reasons for Rejections for Japanese Patent Appl. Serial No. 2012-541491 dated Aug. 28, 2014, 8 pages.
Office Action for Canadian Appl. Ser. No. 2732309 dated Dec. 7, 2015.
Office Action for Canadian Appl. Ser. No. 2743575 dated Jan. 21, 2015 (4 pages).
Office Action for Canadian Appl. Ser. No. 2743575 dated Jun. 11, 2015.
Office Action for Canadian Appl. Ser. No. 2743575 dated Sep. 14, 2015.
Office Action for EPO Appl. Ser. No. 10787404.2 dated May 6, 2015.
Office Action for EPO Appl. Ser. No. 14172592.9 dated Aug. 20, 2015.
Office Action for European Application No. 10787404.2 dated Mar. 26, 2013.
Office Action for Japanese Appl. Ser. No. 2013-501857 dated Jun. 1, 2015.
Office Action for Japanese Appl. Ser. No. 2013-501857 dated Sep. 17, 2014.
Office Action on U.S. Appl. No. 14/731,296 dated Oct. 5, 2016.
Office Action on U.S. Appl. No. 14/945,952 dated Jul. 26, 2016.
Office Action on U.S. Appl. No. 15/194,033 dated Aug. 22, 2016.
Pollak, et al. “Effets de la Stimulation du Noyau Sous-Thalamique Dans La Maladie De Parkinson”, Rev. Neurol (Paris),149, 3, 175-176. Mason, Paris, 1993.
Rousche, et al., “Flexible polyimide-based intracortical electrode arrays with bioactive capability,” IEEE Transactions on Biomedical Engineering 48(3): 361-371 (Mar. 2001).
Second Notice of Reasons for Rejection for Japanese Application No. 2012-541491 dated Apr. 8, 2015.
Sepulveda et al., “Finite Element Analysis of Current Pathways with Implanted Electrodes”, J. Biomed. Eng. 1983, vol. 5, pp. 41-48.
U.S. Corrected Notice of Allowability for U.S. Appl. No. 14/470,356 dated May 18, 2016.
U.S. Notice of Allowance for U.S. Appl. No. 14/287,917 dated Jul. 20, 2015.
U.S. Notice of Allowance for U.S. Appl. No. 14/309,491 dated May 11, 2016.
U.S. Notice of Allowance for U.S. Appl. No. 14/316,154 dated Apr. 20, 2015.
U.S. Notice of Allowance for U.S. Appl. No. 14/470,356 dated Apr. 13, 2016.
U.S. Notice of Allowance for U.S. Appl. No. 14/470,356 dated Mar. 18, 2016.
U.S. Notice of Allowance for U.S. Appl. No. 13/512,936 dated Feb. 20, 2014.
U.S. Notice of Allowance for U.S. Appl. No. 13/512,936 dated Nov. 25, 2013.
U.S. Notice of Allowance for U.S. Appl. No. 13/056,261 dated May 8, 2014.
U.S. Notice of Allowance in U.S. Appl. No. 13/128,821 dated Dec. 24, 2013.
U.S. Notice of Allowance in U.S. Appl. No. 13/128,821 dated Mar. 25, 2014.
U.S. Notice of Allowance on U.S. Appl. No. 13/638,435 dated Sep. 16, 2016.
U.S. Office Action for U.S. Appl. No. 13/128,821 dated Nov. 14, 2013.
U.S. Office Action for U.S. Appl. No. 13/638,435 dated Feb. 10, 2016.
U.S. Office Action for U.S. Appl. No. 13/638,435 dated Jun. 30, 2015.
U.S. Office Action for U.S. Appl. No. 13/638,435 dated Mar. 12, 2015.
U.S. Office Action for U.S. Appl. No. 14/309,491 dated Jul. 28, 2015.
U.S. Office Action for U.S. Appl. No. 14/309,491 dated Mar. 3, 2016.
U.S. Office Action for U.S. Appl. No. 14/470,423 dated Jan. 21, 2016.
U.S. Office Action for U.S. Appl. No. 13/128,821 dated Dec. 14, 2012.
U.S. Office Action for U.S. Appl. No. 13/128,821 dated Apr. 24, 2012.
U.S. Office Action for U.S. Appl. No. 14/316,154 dated Dec. 18, 2014.
U.S. Office Action for U.S. Appl. No. 13/512,936 dated Aug. 14, 2013.
U.S. Office Action for U.S. Appl. No. 13/056,261 dated Jan. 9, 2014.
U.S. Office Action in U.S. Appl. No. 13/056,261 dated Aug. 7, 2013.
U.S. Office Action on U.S. Appl. No. 14/287,917 dated Sep. 26, 2014.
Written Opinion for PCT/EP2010/068658 dated Jun. 1, 2012.
Written Opinion for Singapore Application No. 201103393-3 dated May 2, 2012.
Canadian Office Action for CA 2,732,309 dated Nov. 8, 2016.
U.S. Notice of Allowance on U.S. Appl. No. 14/945,952 dated Dec. 7, 2016.
Non-Final Office Action for U.S. Appl. No. 15/910,278 dated Nov. 26, 2019 (7 pages).
First Office Action for CN 201580019701.2 dated Nov. 15, 2019 (18 pages).
Office Action for CA 3026948 dated Jan. 15, 2020 (4 pages).
Non-Final Office Action on U.S. Appl. No. 15/962,632 dated Mar. 30, 2020 (10 pages).
Non-Final Office Action on U.S. Appl. No. 16/236,716 dated Apr. 29, 2020 (9 pages).
Notice of Allowance on U.S. Appl. No. 15/369766 dated Mar. 5, 2020 (8 pages).
Notice of Allowance on U.S. Appl. No. 15/910278 dated Mar. 9, 2020 (8 pages).
Chinese Office Action on CN 201580019701.2 dated Aug. 17, 2020 (9 pages)
Final Office Action on U.S. Appl. No. 15/962,632 dated Oct. 6, 2020 (13 pages).
International Preliminary Report on Patentability on PCT/IB2019/051635 dated Sep. 17, 2020 (7 pages).
International Preliminary Report on Patentability on PCT/IB2019/053275 dated Nov. 5, 2020 (8 pages).
Related Publications (1)
Number Date Country
20170105641 A1 Apr 2017 US
Provisional Applications (1)
Number Date Country
61994359 May 2014 US